Title,Authors,Platform,Cited_url,Cited_count,Year
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus,"RC Fitzgerald, M di Pietro, K Ragunath, Y Ang, JY Kang, P Watson, ...","Gut 63 (1), 7-42","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8303554189810409009,5676495711962397876",834,2014
Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research,"RC Fitzgerald, R Hardwick, D Huntsman, F Carneiro, P Guilford, V Blair, ...","Journal of medical genetics 47 (7), 436-444",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11020925443911419155,618,2010
Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression,"R Ouatu–Lascar, RC Fitzgerald, G Triadafilopoulos","Gastroenterology 117 (2), 327-335",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5837284034849891568,434,1999
Toward understanding and exploiting tumor heterogeneity,"AA Alizadeh, V Aranda, A Bardelli, C Blanpain, C Bock, C Borowski, ...","Nature medicine 21 (8), 846",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12748584029464635920,375,2015
Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.,"RC Fitzgerald, MB Omary, G Triadafilopoulos","The Journal of clinical investigation 98 (9), 2120-2128",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3665305730356948332,360,1996
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers,"RS van der Post, IP Vogelaar, F Carneiro, P Guilford, D Huntsman, ...","Journal of medical genetics 52 (6), 361-374",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7029111412465711823,282,2015
Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants,"RC Fitzgerald, BA Onwuegbusi, M Bajaj-Elliott, IT Saeed, WR Burnham, ...","Gut 50 (4), 451-459",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16969759974913849896,273,2002
Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study,"SR Kadri, P Lao-Sirieix, M O’Donovan, I Debiram, M Das, JM Blazeby, ...","Bmj 341, c4372",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13227554334542126741,269,2010
Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis,"JMJ Weaver, CS Ross-Innes, N Shannon, AG Lynch, T Forshew, ...","Nature genetics 46 (8), 837",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10850118794436257288,228,2014
Mechanisms and sequelae of E‐cadherin silencing in hereditary diffuse gastric cancer,"M Barber, A Murrell, Y Ito, AT Maia, S Hyland, C Oliveira, V Save, ...",The Journal of Pathology: A Journal of the Pathological Society of Great …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4273478731756017824,219,2008
Mutations in the selenocysteine insertion sequence–binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans,"E Schoenmakers, M Agostini, C Mitchell, N Schoenmakers, L Papp, ...","The Journal of clinical investigation 120 (12), 4220-4235",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4769484519678385673,212,2010
Germline              ,"C Oliveira, J Senz, P Kaurah, H Pinheiro, R Sanges, A Haegert, G Corso, ...","Human molecular genetics 18 (9), 1545-1555",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9076064844997840182,209,2009
Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus,"EL Bird-Lieberman, AA Neves, P Lao-Sirieix, M O'donovan, M Novelli, ...","Nature medicine 18 (2), 315",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14729583016793170608,208,2012
"History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus","SJ Spechler, RC Fitzgerald, GA Prasad, KK Wang","Gastroenterology 138 (3), 854-869",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13818647357333594301,201,2010
Inflammatory gradient in Barrett’s oesophagus: implications for disease complications,"RC Fitzgerald, S Abdalla, BA Onwuegbusi, P Sirieix, IT Saeed, ...","Gut 51 (3), 316-322",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16103989035072981318,176,2002
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus,"DM Levine, WE Ek, R Zhang, X Liu, L Onstad, C Sather, P Lao-Sirieix, ...","Nature genetics 45 (12), 1487",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11767699368081109343,158,2013
Epidemiologic risk factors for Barrett’s esophagus and associated adenocarcinoma,"A Wong, RC Fitzgerald","Clinical Gastroenterology and Hepatology 3 (1), 1-10",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16765312163567687329,150,2005
Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma,"CS Ross-Innes, J Becq, A Warren, RK Cheetham, H Northen, ...","Nature genetics 47 (9), 1038",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6547434560054135081,147,2015
Population-based study reveals new risk-stratification biomarker panel for Barrett's esophagus,"EL Bird–Lieberman, JM Dunn, HG Coleman, P Lao–Sirieix, D Oukrif, ...","Gastroenterology 143 (4), 927-935. e3",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18026281662961440494,146,2012
Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett’s oesophagus,"LB Lovat, K Johnson, GD Mackenzie, BR Clark, MR Novelli, S Davies, ...","Gut 55 (8), 1078-1083",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17521925079084980038,145,2006
Somatic mutant clones colonize the human esophagus with age,"I Martincorena, JC Fowler, A Wabik, ARJ Lawson, F Abascal, MWJ Hall, ...","Science 362 (6417), 911-917",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2385865600088655766,143,2018
In vivo and in vitro evidence for transforming growth factor-β1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma,"JRE Rees, BA Onwuegbusi, VE Save, D Alderson, RC Fitzgerald","Cancer research 66 (19), 9583-9590",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8690858324333998934,142,2006
Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus,"T Benaglia, LD Sharples, RC Fitzgerald, G Lyratzopoulos","Gastroenterology 144 (1), 62-73. e6",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1122558935983629118,139,2013
Molecular basis of Barrett’s oesophagus and oesophageal adenocarcinoma,RC Fitzgerald,"Gut 55 (12), 1810-1820",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1864514330944858408,138,2006
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance,"M Secrier, X Li, N De Silva, MD Eldridge, G Contino, J Bornschein, ...","Nature genetics 48 (10), 1131",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13541987427269180473,136,2016
"Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers","A Saadi, NB Shannon, P Lao-Sirieix, M O’Donovan, E Walker, ...","Proceedings of the National Academy of Sciences 107 (5), 2177-2182",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4377424877747623498,135,2010
Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus: a multi-center case–control study,"CS Ross-Innes, I Debiram-Beecham, M O'Donovan, E Walker, ...","PLoS medicine 12 (1), e1001780",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8223938086040911027,134,2015
Clinical implications of E-cadherin associated hereditary diffuse gastric cancer,"RC Fitzgerald, C Caldas","Gut 53 (6), 775-778",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13049541278720589015,124,2004
Early diagnosis of oesophageal cancer,"EL Bird-Lieberman, RC Fitzgerald","British journal of cancer 101 (1), 1-6",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3281374329848452509,120,2009
"A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia","CJ Peters, JRE Rees, RH Hardwick, JS Hardwick, SL Vowler, CAJ Ong, ...","Gastroenterology 139 (6), 1995-2004. e15",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10368122242052503918,116,2010
Gastrin-induced cyclooxygenase-2 expression in Barrett’s carcinogenesis,"SI Abdalla, P Lao-Sirieix, MR Novelli, LB Lovat, IR Sanderson, ...","Clinical Cancer Research 10 (14), 4784-4792",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12886811006763416889,112,2004
Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus,"RC Fitzgerald, IT Saeed, D Khoo, MJG Farthing, WR Burnham","Digestive diseases and sciences 46 (9), 1892-1898",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3497676611483847588,109,2001
Surface expression of minichromosome maintenance proteins provides a novel method for detecting patients at risk for developing adenocarcinoma in Barrett’s esophagus,"PS Sirieix, M O’Donovan, J Brown, V Save, N Coleman, RC Fitzgerald","Clinical Cancer Research 9 (7), 2560-2566",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=509503191578890291,108,2003
Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at …,"ME Barber, V Save, F Carneiro, S Dwerryhouse, P Lao‐Sirieix, ...",The Journal of Pathology: A Journal of the Pathological Society of Great …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1283516905974386003,105,2008
Non-endoscopic screening biomarkers for Barrett’s oesophagus: from microarray analysis to the clinic,"P Lao-Sirieix, A Boussioutas, SR Kadri, M O’Donovan, I Debiram, M Das, ...","Gut 58 (11), 1451-1459",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12880216488712105360,104,2009
Screening for oesophageal cancer,"P Lao-Sirieix, RC Fitzgerald","Nature reviews Clinical oncology 9 (5), 278",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17768097933235757067,103,2012
"Accuracy, safety, and tolerability of tissue collection by Cytosponge vs endoscopy for evaluation of eosinophilic esophagitis","DA Katzka, DM Geno, A Ravi, TC Smyrk, P Lao-Sirieix, A Miramedi, ...","Clinical Gastroenterology and Hepatology 13 (1), 77-83. e2",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12067472795139914228,102,2015
Nitric oxide and acid induce double-strand DNA breaks in Barrett’s esophagus carcinogenesis via distinct mechanisms,"NJ Clemons, KEL McColl, RC Fitzgerald","Gastroenterology 133 (4), 1198-1209",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18278884738656792342,101,2007
Recent developments in the molecular characterization of Barrett’s esophagus,"RC Fitzgerald, G Triadafilopoulos","Digestive Diseases 16 (2), 63-80",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=210602639825979169,101,1998
Oesophageal cancer,"EC Smyth, J Lagergren, RC Fitzgerald, F Lordick, MA Shah, P Lagergren, ...","Nature reviews Disease primers 3, 17048",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=457207395595387815,97,2017
A review of the current understanding and clinical utility of miRNAs in esophageal cancer,"NS Sakai, E Samia-Aly, M Barbera, RC Fitzgerald","Seminars in cancer biology 23 (6), 512-521",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9233273773608789874,92,2013
Treatment for Barrett's oesophagus,"JRE Rees, P Lao‐Sirieix, A Wong, RC Fitzgerald",Cochrane Database of Systematic Reviews,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17297609997637467474,89,2010
Precision prevention of oesophageal adenocarcinoma,"TL Vaughan, RC Fitzgerald","Nature Reviews Gastroenterology & Hepatology 12 (4), 243",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6882446935504924339,86,2015
Cyclin A immunocytology as a risk stratification tool for Barrett's esophagus surveillance,"P Lao-Sirieix, L Lovat, RC Fitzgerald","Clinical Cancer Research 13 (2), 659-665",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2798666961084972962,86,2007
Sweet's syndrome,"RL Fitzgerald, EI McBURNEY, LT Nesbitt Jr","International journal of dermatology 35 (1), 9-15",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3347148216032636566,85,1996
Altered sodium-hydrogen exchange activity is a mechanism for acid-induced hyperproliferation in Barrett’s esophagus,"RC Fitzgerald, MB Omary, G Triadafilopoulos",American Journal of Physiology-Gastrointestinal and Liver Physiology 275 (1 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15242987065221880251,84,1998
Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett's esophagus,"MK Shariff, EL Bird-Lieberman, M O'Donovan, Z Abdullahi, X Liu, ...","Gastrointestinal endoscopy 75 (5), 954-961",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8477605356920397850,82,2012
Familial gastric cancer–aetiology and pathogenesis,"M Barber, RC Fitzgerald, C Caldas","Best Practice & Research Clinical Gastroenterology 20 (4), 721-734",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18035264438602322643,77,2006
Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal …,"XY Goh, JRE Rees, AL Paterson, SF Chin, JC Marioni, V Save, ...","Gut 60 (10), 1317-1326",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5346247725614375766,74,2011
Retinoic acid-induced glandular differentiation of the oesophagus,"CL Chang, P Lao-Sirieix, V Save, GDLC Mendez, R Laskey, ...","Gut 56 (7), 906-917",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6752471354329488962,72,2007
Barrett’s oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?,RC Fitzgerald,"Gut 54 (suppl 1), i21-i26",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16608692980618027682,72,2005
Acid modulation of HT29 cell growth and differentiation. An in vitro model for Barrett's esophagus,"RC Fitzgerald, MB Omary, G Triadafilopoulos","Journal of cell science 110 (5), 663-671",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11267578251732857848,71,1997
Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett’s esophagus,"C Palles, L Chegwidden, X Li, JM Findlay, G Farnham, FC Giner, ...","Gastroenterology 148 (2), 367-378",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12327992660872311387,69,2015
Biomarkers in Barrett’s esophagus and esophageal adenocarcinoma: predictors of progression and prognosis,"CAJ Ong, P Lao-Sirieix, RC Fitzgerald","World journal of gastroenterology: WJG 16 (45), 5669",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3289302752643349619,68,2010
Impaired transforming growth factor β signalling in Barrett’s carcinogenesis due to frequent SMAD4 inactivation,"BA Onwuegbusi, A Aitchison, SF Chin, T Kranjac, I Mills, Y Huang, ...","Gut 55 (6), 764-774",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15858614345756033115,68,2006
Effect of inflammation on cyclooxygenase (COX)-2 expression in benign and malignant oesophageal cells,"SI Abdalla, IR Sanderson, RC Fitzgerald","Carcinogenesis 26 (9), 1627-1633",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7848695294980154361,66,2005
Facilitating a culture of responsible and effective sharing of cancer genome data,"LL Siu, M Lawler, D Haussler, BM Knoppers, J Lewin, DJ Vis, RG Liao, ...","Nature medicine 22 (5), 464",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15199583458485116270,65,2016
Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma,"CAJ Ong, J Shapiro, KS Nason, JM Davison, X Liu, C Ross-Innes, ...","Journal of clinical oncology 31 (12), 1576",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3255204442800167098,65,2013
Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis,"P Gharahkhani, RC Fitzgerald, TL Vaughan, C Palles, I Gockel, ...","The Lancet Oncology 17 (10), 1363-1373",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5296160115452632736,62,2016
Genetic predisposition to gastro-oesophageal cancer,"P Lao-Sirieix, C Caldas, RC Fitzgerald","Current opinion in genetics & development 20 (3), 210-217",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2465733038671272195,62,2010
"DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus","MA Alvi, X Liu, M O'Donovan, R Newton, L Wernisch, NB Shannon, ...","Clinical Cancer Research 19 (4), 878-888",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13061041524742998976,61,2013
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial,"JAZ Jankowski, J de Caestecker, SB Love, G Reilly, P Watson, S Sanders, ...","The Lancet 392 (10145), 400-408",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8119578000247682694,60,2018
"Barrett’s oesophagus, dysplasia and pharmacologic acid suppression","RC Fitzgerald, R Lascar, G Triadafilopoulos","Alimentary pharmacology & therapeutics 15 (3), 269-276",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2667211636947204367,60,2001
"Quality indicators for the management of Barrett’s esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American …","P Sharma, DA Katzka, N Gupta, J Ajani, N Buttar, A Chak, D Corley, ...","Gastroenterology 149 (6), 1599-1606",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9879120137227191465,59,2015
Subretinal hyperreflective material in the comparison of age-related macular degeneration treatments trials,"AS Willoughby, G Ying, CA Toth, MG Maguire, RE Burns, JE Grunwald, ...","Ophthalmology 122 (9), 1846-1853. e5",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3218927567264310461,56,2015
Diagnostic Kits and Methods for Oesophageal Abnormalities,"RC Fitzgerald, R Hardwick","US Patent App. 12/083,751",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12399402783363879116,53,2009
The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus,"M di Pietro, DF Boerwinkel, MK Shariff, X Liu, E Telakis, P Lao-Sirieix, ...","Gut 64 (1), 49-56",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15866221519698618390,52,2015
Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus,"M di Pietro, P Lao-Sirieix, S Boyle, A Cassidy, D Castillo, A Saadi, ...","Proceedings of the National Academy of Sciences 109 (23), 9077-9082",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11652572655683682060,52,2012
Identification and clinical implementation of biomarkers for Barrett's esophagus,"S Varghese, P Lao–Sirieix, RC Fitzgerald","Gastroenterology 142 (3), 435-441. e2",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=466226105883328223,51,2012
Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study,"CS Ross-Innes, H Chettouh, A Achilleos, N Galeano-Dalmau, ...","The Lancet Gastroenterology & Hepatology 2 (1), 23-31",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14272680892681794709,50,2017
Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance,"YC Lim, M di Pietro, M O'Donovan, S Richardson, I Debiram, ...","Gastrointestinal endoscopy 80 (1), 78-87",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18024697218599763094,48,2014
Screening for Barrett’s esophagus,"M Di Pietro, D Chan, RC Fitzgerald, KK Wang","Gastroenterology 148 (5), 912-923",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4319826885579739267,44,2015
"Body mass index, smoking, and alcohol and risks of Barrett’s esophagus and esophageal adenocarcinoma: a UK prospective cohort study","M Yates, E Cheong, R Luben, L Igali, R Fitzgerald, KT Khaw, A Hart","Digestive diseases and sciences 59 (7), 1552-1559",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3348864181740261593,44,2014
 Acid Exposure has a Differential Effect on Apoptotic and Proliferative Pathways in a Barrett's Adenocarcinoma Cell Line,"C Morgan, W Alazawi, P Sirieix, T Freeman, N Coleman, R Fitzgerald","The American journal of gastroenterology 99 (2), 218",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17171750794383358807,44,2004
Cellular origin of Barrett's metaplasia and oesophageal stem cells,"M Barbera, RC Fitzgerald","Biochemical society transactions 38 (2), 370-373",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9314852602637570646,39,2010
Developing a nonendoscopic screening test for Barrett’s esophagus,"S Kadri, P Lao-Sirieix, RC Fitzgerald","Biomarkers in medicine 5 (3), 397-404",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13012110353873900084,38,2011
E-cadherin mutations and hereditary gastric cancer: prevention by resection?,"RC Fitzgerald, C Caldas","Digestive Diseases 20 (1), 23-31",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10658192679850649116,37,2002
Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett's oesophagus with low-grade dysplasia,"M di Pietro, RC Fitzgerald","Gut 67 (2), 392-393",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4093473860811579487,36,2018
Barrett's oesophagus and adenocarcinoma,"CPJ Caygill, A Watson, P Lao-Sirieix, RC Fitzgerald","World Journal of Surgical Oncology 2 (1), 12",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12902095734703900672,36,2004
Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis,"P Lao-Sirieix, R Brais, L Lovat, N Coleman, RC Fitzgerald","Neoplasia (New York, NY) 6 (6), 751",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8525296832753422217,36,2004
Short segment columnar-lined oesophagus: an underestimated cancer risk? A large cohort study of the relationship between Barrett's columnar-lined oesophagus segment length and …,"PAC Gatenby, CPJ Caygill, JR Ramus, A Charlett, RC Fitzgerald, ...","European journal of gastroenterology & hepatology 19 (11), 969-975",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11750196007093033363,35,2007
Upright versus supine reflux in gastroesophageal reflux disease,"R Ouatu‐Lascar, OS Lin, RC Fitzgerald, G Triadafilopoulos","Journal of gastroenterology and hepatology 16 (11), 1184-1190",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10712750100678792210,35,2001
Effect of acid suppression on molecular predictors for esophageal cancer,"P Lao-Sirieix, A Roy, C Worrall, SL Vowler, S Gardiner, RC Fitzgerald","Cancer Epidemiology and Prevention Biomarkers 15 (2), 288-293",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2836614979433118560,34,2006
The impact of prophylactic total gastrectomy on health-related quality of life: a prospective cohort study,"E Worster, X Liu, S Richardson, RH Hardwick, S Dwerryhouse, C Caldas, ...","Annals of surgery 260 (1), 87-93",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2416598325182930048,33,2014
A systematic approach to therapeutic target selection in oesophago-gastric cancer,"AL Paterson, NB Shannon, P Lao-Sirieix, CAJ Ong, CJ Peters, ...","Gut 62 (10), 1415-1424",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13462431488004513723,33,2013
A novel role for the retinoic acid-catabolizing enzyme CYP26A1 in Barrett's associated adenocarcinoma,"CL Chang, E Hong, P Lao-Sirieix, RC Fitzgerald","Oncogene 27 (21), 2951",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4695261299500704366,33,2008
"Endoscopic management of early adenocarcinoma and squamous cell carcinoma of the esophagus: screening, diagnosis, and therapy","M di Pietro, MI Canto, RC Fitzgerald","Gastroenterology 154 (2), 421-436",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13153290144905128317,32,2018
Characterization of the timing and prevalence of receptor tyrosine kinase expression changes in oesophageal carcinogenesis,"AL Paterson, M O'Donovan, E Provenzano, LJ Murray, HG Coleman, ...","The Journal of pathology 230 (1), 118-128",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11958718925616067409,32,2013
Generation and validation of a revised classification for oesophageal and junctional adenocarcinoma,"CJ Peters, RH Hardwick, SL Vowler, RC Fitzgerald",British Journal of Surgery: Incorporating European Journal of Surgery and …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5538640142710548689,32,2009
CTCL in patients under 20 years of age: a series of five cases,"PR Hickham, EI McBurney, RL Fitzgerald","Pediatric dermatology 14 (2), 93-97",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6964117479918981892,32,1997
International cancer seminars: a focus on esophageal squamous cell carcinoma,"G Murphy, V McCormack, B Abedi-Ardekani, M Arnold, MC Camargo, ...","Annals of Oncology 28 (9), 2086-2093",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14375754010804151659,31,2017
"Complex diseases in gastroenterology and hepatology: GERD, Barrett’s, and esophageal adenocarcinoma",RC Fitzgerald,"Clinical Gastroenterology and Hepatology 3 (6), 529-537",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=996394764702633682,31,2005
Methylation panel is a diagnostic biomarker for Barrett’s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens,"H Chettouh, O Mowforth, N Galeano-Dalmau, N Bezawada, C Ross-Innes, ...","Gut 67 (11), 1942-1949",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5851508820994176092,30,2018
Accuracy and safety of the cytosponge for assessing histologic activity in eosinophilic esophagitis: a two-center study,"DA Katzka, TC Smyrk, JA Alexander, DM Geno, RMA Beitia, AO Chang, ...","The American journal of gastroenterology 112 (10), 1538",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9062203917135611752,30,2017
A non-endoscopic device to sample the oesophageal microbiota: a case-control study,"DRF Elliott, AW Walker, M O'Donovan, J Parkhill, RC Fitzgerald","The lancet Gastroenterology & hepatology 2 (1), 32-42",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2697065565086212875,30,2017
Outcomes of eyes with lesions composed of> 50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT),"MM Altaweel, E Daniel, DF Martin, RA Mittra, JE Grunwald, MM Lai, ...","Ophthalmology 122 (2), 391-398. e5",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11670548299487068735,30,2015
The human squamous oesophagus has widespread capacity for clonal expansion from cells at diverse stages of differentiation,"M Barbera, M di Pietro, E Walker, C Brierley, S MacRae, BD Simons, ...","Gut 64 (1), 11-19",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11899096298439287469,30,2015
Selective loss of TGFβ Smad-dependent signalling prevents cell cycle arrest and promotes invasion in oesophageal adenocarcinoma cell lines,"BA Onwuegbusi, JRE Rees, P Lao-Sirieix, RC Fitzgerald","PloS one 2 (1), e177",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16856276000484448679,30,2007
The evolving genomic landscape of Barrett’s esophagus and esophageal adenocarcinoma,"G Contino, TL Vaughan, D Whiteman, RC Fitzgerald","Gastroenterology 153 (3), 657-673. e1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3405617323472085786,29,2017
The'–omics' revolution and oesophageal adenocarcinoma,"JMJ Weaver, CS Ross-Innes, RC Fitzgerald","Nature reviews Gastroenterology & hepatology 11 (1), 19",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1923493559164149496,29,2014
Barrett's oesophagus and associated adenocarcinoma–a UK perspective,RC Fitzgerald,"Alimentary pharmacology & therapeutics 20, 45-49",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2251921440782447854,29,2004
Molecular markers for Barrett's esophagus and its progression to cancer,"DRF Elliott, RC Fitzgerald","Current opinion in gastroenterology 29 (4), 437-445",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2764071424452244350,28,2013
Barrett’s esophagus and cancer risk: how research advances can impact clinical practice,"M Di Pietro, D Alzoubaidi, RC Fitzgerald","Gut and liver 8 (4), 356",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10357188970936352962,27,2014
Amplification of TRIM44: pairing a prognostic target with potential therapeutic strategy,"CAJ Ong, NB Shannon, CS Ross-Innes, M O’Donovan, OM Rueda, D Hu, ...","Journal of the National Cancer Institute 106 (5), dju050",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16821266210625317811,27,2014
Pregnancy after prophylactic total gastrectomy,"P Kaurah, R Fitzgerald, S Dwerryhouse, DG Huntsman","Familial cancer 9 (3), 331-334",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5886134980022801957,26,2010
Familial gastric cancer–clinical management,"RC Fitzgerald, C Caldas","Best Practice & Research Clinical Gastroenterology 20 (4), 735-743",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4019346305495716717,26,2006
Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics,"X Li, HE Francies, M Secrier, J Perner, A Miremadi, N Galeano-Dalmau, ...","Nature communications 9 (1), 2983",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11793351855699678152,25,2018
Genetic progression of Barrett’s oesophagus to oesophageal adenocarcinoma,"EM Gregson, J Bornschein, RC Fitzgerald","British journal of cancer 115 (4), 403",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2844039759079631832,25,2016
Genetics and prevention of oesophageal adenocarcinoma,RC Fitzgerald,"Tumor Prevention and Genetics III, 35-46",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1339249386765847396,25,2005
Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status,"EZ Mi, EZ Mi, M di Pietro, M O’Donovan, RH Hardwick, S Richardson, ...","Gastrointestinal endoscopy 87 (2), 408-418",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13191905810623656374,24,2018
Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma,"N De Silva, L Schulz, A Paterson, W Qain, M Secrier, E Godfrey, H Cheow, ...","British journal of cancer 113 (9), 1305",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13824786717249940984,24,2015
Non-endoscopic immunocytological screening test for Barrett’s oesophagus,"P Lao-Sirieix, B Rous, M O’Donovan, RH Hardwick, I Debiram, ...","Gut 56 (7), 1033-1034",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4254388187716556400,24,2007
Esophageal manifestations of rheumatic disorders,"RC Fitzgerald, G Triadafilopoulos","Seminars in arthritis and rheumatism 26 (4), 641-666",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2919055192441627100,24,1997
Integrative post-genome-wide association analysis of ,"MF Buas, DM Levine, KW Makar, H Utsugi, L Onstad, X Li, PC Galipeau, ...","Carcinogenesis 35 (12), 2740-2747",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2782179441523511418,23,2014
Barrett’s oesophagus: an ideal model to study cancer genetics,"M Di Pietro, RC Fitzgerald","Human genetics 126 (2), 233-246",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14421477580725178109,23,2009
Determining risk of Barrett’s esophagus and esophageal adenocarcinoma based on epidemiologic factors and genetic variants,"J Dong, MF Buas, P Gharahkhani, BJ Kendall, L Onstad, S Zhao, ...","Gastroenterology 154 (5), 1273-1281. e3",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3479398180953989273,22,2018
Gastro-esophageal reflux disease symptoms and demographic factors as a pre-screening tool for Barrett’s esophagus,"X Liu, A Wong, SR Kadri, A Corovic, M O’Donovan, P Lao-Sirieix, ...","PLoS One 9 (4), e94163",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17150639047744146320,22,2014
Nitric oxide-mediated invasion in Barrett's high-grade dysplasia and adenocarcinoma,"NJ Clemons, NB Shannon, LR Abeyratne, CE Walker, A Saadi, ...","Carcinogenesis 31 (9), 1669-1675",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4893889583068078599,22,2010
Pilot randomized crossover study comparing the efficacy of transnasal disposable endosheath with standard endoscopy to detect Barrett’s esophagus,"MK Shariff, S Varghese, M O’Donovan, Z Abdullahi, X Liu, RC Fitzgerald, ...","Endoscopy 48 (02), 110-116",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=677157302710486800,21,2016
Mobile element insertions are frequent in oesophageal adenocarcinomas and can mislead paired-end sequencing analysis,"AL Paterson, JMJ Weaver, MD Eldridge, S Tavaré, RC Fitzgerald, ...","BMC genomics 16 (1), 473",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9153727537485302811,21,2015
Endoscopic TriModal imaging and biomarkers for neoplasia conjoined: a feasibility study in Barrett’s esophagus,"DF Boerwinkel, M Di Pietro, X Liu, MK Shariff, P Lao-Sirieix, CE Walker, ...","Diseases of the Esophagus 27 (5), 435-443",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7389191149045469143,21,2014
"Histopathological, molecular, and genetic profile of hereditary diffuse gastric cancer: current knowledge and challenges for the future","RS van der Post, I Gullo, C Oliveira, LH Tang, HI Grabsch, M O’Donovan, ...","Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17541220396251549033,20,2016
Pilot study of cytological testing for oesophageal squamous cell dysplasia in a high-risk area in Northern Iran,"G Roshandel, S Merat, M Sotoudeh, M Khoshnia, H Poustchi, ...","British journal of cancer 111 (12), 2235",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12301882494923686821,20,2014
Location of lymph node involvement in patients with esophageal adenocarcinoma predicts survival,"AK Talsma, CAJ Ong, X Liu, P van Hagen, JJB Van Lanschot, HW Tilanus, ...","World journal of surgery 38 (1), 106-113",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6842588587531412895,20,2014
Screening and risk stratification for Barrett's esophagus: how to limit the clinical impact of the increasing incidence of esophageal adenocarcinoma,"M di Pietro, RC Fitzgerald","Gastroenterology Clinics 42 (1), 155-173",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13674614445940447066,20,2013
Progressive silencing of p14ARF in oesophageal adenocarcinoma,"Y Huang, CJ Peters, RC Fitzgerald, RA Gjerset","Journal of cellular and molecular medicine 13 (2), 398-409",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7756431661944587867,20,2009
Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma,"MF Buas, Q He, LG Johnson, L Onstad, DM Levine, AP Thrift, ...","Gut 66 (10), 1739-1747",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13058108485507875614,19,2017
Role of the micro-environment in Barrett's carcinogenesis,"P Lao-Sirieix, RC Fitzgerald","Biochemical Society Transactions 38 (2), 327-330",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5597173686099392867,19,2010
Systematic review: the application of molecular pathogenesis to prevention and treatment of oesophageal adenocarcinoma,"CJ Peters, RC Fitzgerald","Alimentary pharmacology & therapeutics 25 (11), 1253-1269",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5914827194293130970,19,2007
Gas-insulated switchgear device,"C Piazza, G Guerra","US Patent 6,683,267","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2701765185076738884,3204505621339287749",19,2004
Barrett's esophagus,"EL Bird-Lieberman, RC Fitzgerald","Gastroenterology Clinics of North America 37 (4), 921-942",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9614556367225058402,18,2008
Comparative genomic hybridization of esophageal adenocarinoma and squamous cell carcinoma cell lines,"M Su, SF Chin, XY Li, RC Fitzgerald","Diseases of the Esophagus 19 (1), 10-14",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10938514630654255256,18,2006
"Acid, Helicobacter and immunity: a new paradigm for oesophagogastric cancer","MJG Farthing, R Fitzgerald, ZW Zhang","Journal of Physiology-Paris 95 (1-6), 423-427",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1741348485814198066,18,2001
An investigation of the factors effecting high-risk individuals’ decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC),"N Hallowell, S Badger, S Richardson, C Caldas, RH Hardwick, ...","Familial cancer 15 (4), 665-676",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10541593479984455357,17,2016
Analysis of dysplasia in patients with Barrett’s esophagus based on expression pattern of 90 genes,"S Varghese, R Newton, CS Ross-Innes, P Lao-Sirieix, KK Krishnadath, ...","Gastroenterology 149 (6), 1511-1518. e5",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4095463238107036535,17,2015
MiRNA-related SNPs and risk of esophageal adenocarcinoma and Barrett’s esophagus: post genome-wide association analysis in the BEACON consortium,"MF Buas, L Onstad, DM Levine, HA Risch, WH Chow, G Liu, ...","PLoS one 10 (6), e0128617",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16071933395834496905,17,2015
Research advances in esophageal diseases: bench to bedside,"M di Pietro, RC Fitzgerald",F1000prime reports 5,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10114272235783043554,17,2013
Physiological and molecular analysis of acid loading mechanisms in squamous and columnar-lined esophagus,"P Lao-Sirieix, A Corovic, J Jankowski, A Lowe, G Triadafilopoulos, ...","Diseases of the Esophagus 21 (6), 529-538",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14956297024623525556,17,2008
Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study,"E Fewings, A Larionov, J Redman, MA Goldgraben, J Scarth, ...","The Lancet Gastroenterology & Hepatology 3 (7), 489-498",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1744289189967914723,16,2018
The landscape of somatic mutation in normal colorectal epithelial cells,"H Lee-Six, S Olafsson, P Ellis, RJ Osborne, MA Sanders, L Moore, ...","Nature 574 (7779), 532-537",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17667192739429788201,15,2019
Autofluorescence-directed confocal endomicroscopy in combination with a three-biomarker panel can inform management decisions in Barrett’s esophagus,"M Di Pietro, EL Bird-Lieberman, X Liu, T Nuckcheddy-Grant, H Bertani, ...","The American journal of gastroenterology 110 (11), 1549",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=956123351301636074,15,2015
Diagnosis and treatment of Barrett's oesophagus.,"YC Lim, RC Fitzgerald",British medical bulletin 107 (1),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9770472416986069585,15,2013
Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma,"F Noble, MA Lloyd, R Turkington, E Griffiths, M O'Donovan, JR O'Neill, ...","British Journal of Surgery 104 (13), 1816-1828",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17453542410199610974,14,2017
Recurrence of intestinal metaplasia and early neoplasia after endoscopic eradication therapy for Barrett’s esophagus: a systematic review and meta-analysis,"LL Fujii-Lau, B Cinnor, N Shaheen, S Gaddam, S Komanduri, ...","Endoscopy international open 5 (06), E430-E449",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12147038945495353734,14,2017
Range of pathologies diagnosed using a minimally invasive capsule sponge to evaluate patients with reflux symptoms,"AL Paterson, P Lao‐Sirieix, M O'Donovan, I Debiram‐Beecham, ...","Histopathology 70 (2), 203-210",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3081129401227500190,14,2017
Design and validation of a near-infrared fluorescence endoscope for detection of early esophageal malignancy,"DJ Waterhouse, J Joseph, AA Neves, M di Pietro, KM Brindle, ...","Journal of biomedical optics 21 (8), 084001",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5879375375965714490,14,2016
"Biomarkers in barrett’s esophagus: role in diagnosis, risk stratification, and prediction of response to therapy","A Bansal, RC Fitzgerald","Gastroenterology Clinics 44 (2), 373-390",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18379211439120672007,14,2015
1004 radiofrequency ablation in Barrett's esophagus with confirmed low-grade dysplasia: interim results of a European Multicenter Randomized Controlled Trial (SURF),"KYN Phoa, FG van Vilsteren, RE Pouw, BL Weusten, EJ Schoon, ...","Gastroenterology 144 (5), S-187",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=266511152177279851,14,2013
Cellular mechanisms of Barrett's esophagus development,"M Barbera, RC Fitzgerald","Surgical Oncology Clinics 18 (3), 393-410",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14413799775814429902,14,2009
The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic,"AM Frankell, S Jammula, X Li, G Contino, S Killcoyne, S Abbas, J Perner, ...","Nature genetics 51 (3), 506",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16356972674057602323,13,2019
Open chromatin profiling identifies AP1 as a transcriptional regulator in oesophageal adenocarcinoma,"E Britton, C Rogerson, S Mehta, Y Li, X Li, RC Fitzgerald, YS Ang, ...","Plos genetics 13 (8), e1006879",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17188243979008226637,13,2017
Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1,"E Garcia, A Hayden, C Birts, E Britton, A Cowie, K Pickard, M Mellone, ...","Scientific reports 6, 32417","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11848157487915878919,59299233831129677",13,2016
Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma,"WE Ek, K Lagergren, M Cook, AH Wu, CC Abnet, D Levine, WH Chow, ...","International journal of cancer 138 (5), 1146-1152",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5056086834007327824,13,2016
Fluorescence imaging for the detection of early neoplasia in Barrett’s esophagus: old looks or new vision?,"DF Boerwinkel, MK Shariff, M di Pietro, JA Holz, MC Aalders, WL Curvers, ...","European journal of gastroenterology & hepatology 26 (7), 691-698",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6162821475006042604,13,2014
Clinical puzzle: Barrett’s oesophagus,"M di Pietro, CJ Peters, RC Fitzgerald","Disease models & mechanisms 1 (1), 26-31",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5634515611164091742,13,2008
Novel adaptation of brush cytology technique for short-term primary culture of squamous and Barrett's esophageal cells,"RC Fitzgerald, MJG Farthing, G Triadafilopoulos","Gastrointestinal endoscopy 54 (2), 186-189",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9569276717522817642,13,2001
Safety and acceptability of esophageal cytosponge cell collection device in a pooled analysis of data from individual patients,"W Januszewicz, WK Tan, K Lehovsky, I Debiram-Beecham, ...","Clinical Gastroenterology and Hepatology 17 (4), 647-656. e1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9952163177914092751,12,2019
Selection and application of tissue microRNAs for nonendoscopic diagnosis of Barrett’s esophagus,"X Li, S Kleeman, SB Coburn, C Fumagalli, J Perner, S Jammula, ...","Gastroenterology 155 (3), 771-783. e3",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17403354319364645941,12,2018
New screening techniques in Barrett’s esophagus: great ideas or great practice?,"SJ Spechler, DA Katzka, RC Fitzgerald","Gastroenterology 154 (6), 1594-1601",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9972379842941295130,12,2018
The discovery and validation of biomarkers for the diagnosis of esophageal squamous dysplasia and squamous cell carcinoma,"G Couch, JE Redman, L Wernisch, R Newton, S Malhotra, SM Dawsey, ...","Cancer Prevention Research 9 (7), 558-566",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12546645843144498628,12,2016
The influence of symptom type and duration on the fate of the metaplastic columnar‐lined Barrett’s oesophagus,"PAC Gatenby, JR Ramus, CPJ Caygill, RC Fitzgerald, A Charlett, ...","Alimentary pharmacology & therapeutics 29 (10), 1096-1105",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15896056040449871446,12,2009
The psychosocial impact of undergoing prophylactic total gastrectomy (PTG) to manage the risk of hereditary diffuse gastric cancer (HDGC),"N Hallowell, J Lawton, S Badger, S Richardson, RH Hardwick, C Caldas, ...","Journal of genetic counseling 26 (4), 752-762",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17313848413396948636,11,2017
Dedicated Barrett's surveillance sessions managed by trained endoscopists improve dysplasia detection rate,"J Ooi, P Wilson, G Walker, P Blaker, S DeMartino, J O’Donohue, D Reffitt, ...","Endoscopy 49 (06), 524-528",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14979394198837687535,11,2017
Impact of mutations in Toll-like receptor pathway genes on esophageal carcinogenesis,"DRF Elliott, J Perner, X Li, MF Symmons, B Verstak, M Eldridge, L Bower, ...","PLoS genetics 13 (5), e1006808",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10558212669930095012,11,2017
Biomarkers for dysplastic Barrett’s: ready for prime time?,"EM Gregson, RC Fitzgerald","World journal of surgery 39 (3), 568-577",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8753963964479276102,11,2015
The pathogenesis of Barrett's esophagus,"RC Fitzgerald, MJG Farthing","Gastrointestinal Endoscopy Clinics 13 (2), 233-255",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1974017778586199855,11,2003
Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of …,"J Offman, B Muldrew, M O’Donovan, I Debiram-Beecham, F Pesola, ...","BMC cancer 18 (1), 784",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14172799267454108566,10,2018
Systematic assessment with I-SCAN magnification endoscopy and acetic acid improves dysplasia detection in patients with Barrett’s esophagus,"G Lipman, R Bisschops, V Sehgal, J Ortiz-Fernández-Sordo, R Sweis, ...","Endoscopy 49 (12), 1219-1228",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8319228264752817930,10,2017
A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre-and post-chemotherapy,"A Noorani, J Bornschein, AG Lynch, M Secrier, A Achilleos, M Eldridge, ...","Genome research 27 (6), 902-912",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4841326855459829885,10,2017
Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts,"T Sawas, S Killcoyne, PG Iyer, KK Wang, TC Smyrk, JB Kisiel, Y Qin, ...","Gastroenterology 155 (6), 1720-1728. e4",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6221805949457585766,9,2018
Ablative mucosectomy is the procedure of choice to prevent Barrett’s cancer,RC Fitzgerald,"Gut 52 (1), 16-17",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16520255860259653139,9,2003
"Acceptability, accuracy, and safety of disposable transnasal capsule endoscopy for Barrett's esophagus screening","SS Sami, PG Iyer, P Pophali, M Halland, M di Pietro, ...","Clinical Gastroenterology and Hepatology 17 (4), 638-646. e1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2989156906333275600,8,2019
"Past, present and future of Barrett's oesophagus","WK Tan, M di Pietro, RC Fitzgerald","European Journal of Surgical Oncology (EJSO) 43 (7), 1148-1160",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14014844752311977010,8,2017
Alternatives to traditional per-oral endoscopy for screening,"J Offman, RC Fitzgerald","Gastrointestinal Endoscopy Clinics 27 (3), 379-396",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5352389773066136906,8,2017
Whole-genome sequencing of nine esophageal adenocarcinoma cell lines,"G Contino, MD Eldridge, M Secrier, L Bower, RF Elliott, J Weaver, ...",F1000Research 5,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17252965211295799807,8,2016
54 evaluation of a minimally-invasive cytosponge esophageal cell collection system in patients with Barrett's esophagus,"P Lao-Sirieix, I Debiram-Beecham, K Sarah, L Gadeke, A Bincy, ...","Gastroenterology 148 (4), S-16",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13738310575111409790,8,2015
Barrett's Esophagus Translational Research Network (BETRNet): the pivotal role of multi-institutional collaboration in esophageal adenocarcinoma research,"JA Abrams, HD Appelman, DG Beer, LD Berry, A Chak, GW Falk, ...","Gastroenterology 146 (7), 1586-1590",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13963118396252579191,8,2014
958 Time: A Prospective Study Combining Endoscopic Trimodal Imaging and Molecular Endpoints to Improve Risk Stratification in Barrett's Esophagus,"KM Shariff, M di Pietro, DF Boerwinkel, X Liu, E Telakis, P Lao-Sirieix, ...","Gastroenterology 142 (5), S-165",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13738720126127825234,8,2012
Su1088 Non-Endoscopic Diagnostic Tests for Esophageal Diseases and H. pylori Using the Cytosponge,"M O'Donovan, P Lao-Sirieix, R Fitzgerald","Gastroenterology 142 (5), S-421",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18022874202800218459,8,2012
Pre-invasive disease: Pathogenesis and clinical management,RC Fitzgerald,Springer Science & Business Media,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9968023518942086594,8,2010
Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma,"JK Blayney, L Cairns, G Li, N McCabe, L Stevenson, CJ Peters, NB Reid, ...","Oncotarget 9 (26), 18518",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11217060903687428213,7,2018
The use of molecular markers in predicting dysplasia and guiding treatment,"S Zeki, RC Fitzgerald","Best practice & research Clinical gastroenterology 29 (1), 113-124",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4478327671623164638,7,2015
Targeting care in Barrett's oesophagus,"S Zeki, RC Fitzgerald","Clinical Medicine 14 (Suppl 6), s78-s83",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12039897163003491524,7,2014
Distinct cytokine patterns in Barrett's oesophagus and associated adenocarcinoma: Evidence for a shift tewards a Th2 response,"BA Onwuegbusi, RC Fitzgerald, M Bajaj-Elliott, WR Burnham, MJ Farthing","Gastroenterology 118 (4), A37",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17710703139905995368,7,2000
Detection of early neoplasia in Barrett’s esophagus using lectin-based near-infrared imaging: an ex vivo study on human tissue,"AA Neves, M Di Pietro, M O’Donovan, DJ Waterhouse, SE Bohndiek, ...","Endoscopy 50 (06), 618-625",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1692357626598219935,6,2018
Exploring diagnostic and therapeutic implications of endoscopic mucosal resection in EUS-staged T2 esophageal adenocarcinoma,"AW Gotink, MCW Spaander, M Doukas, TJ Tang, P Didden, ...","Endoscopy 49 (10), 941-948","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15025835516255659476,3741605521199719646",6,2017
Pan-cancer analysis of whole genomes reveals driver rearrangements promoted by LINE-1 retrotransposition in human tumours,"B Rodriguez-Martin, EG Alvarez, A Baez-Ortega, J Demeulemeester, ...","BioRxiv, 179705",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8623981764810800448,6,2017
Polymorphisms in genes of relevance for oestrogen and oxytocin pathways and risk of Barrett’s oesophagus and oesophageal adenocarcinoma: a pooled analysis from the BEACON …,"K Lagergren, WE Ek, D Levine, WH Chow, L Bernstein, AG Casson, ...","PloS one 10 (9), e0138738",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2763633737695776473,6,2015
Let's not jump to conclusions regarding low-grade dysplasia in Barrett's esophagus,"JJ Bergman, M Vieth, RC Fitzgerald","Gastroenterology 142 (5), e18-e19",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1520053419067617678,6,2012
Where is the truth when it comes to cancer risk in Barrett's esophagus?,"M di Pietro, M O'Donovan, RC Fitzgerald","Gastroenterology 142 (5), 1245-1247",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7459649238532376057,6,2012
Immediate and early gene response to in vitro acid exposure in a Barrett's adenocarcinoma cell line,"C Morgan, W Alazawi, P Sirieix, T Freeman, N Coleman, R Fitzgerald","Gut 52, A44-A45",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7311989914357381621,6,2003
The pathogenesis of Barrett’s esophagus: A process in continuum or discontinuum,"RC Fitzgerald, MJG Farthing","Current gastroenterology reports 2 (6), 421-424",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6901380080646156739,6,2000
Differential degree of inflammation and cytokine expression in distal compared with proximal Barrett's oesophagus may explain site specific disease complications,"RC Fitzgerald, B Onwuegbusi, IT Saeed, WR Burnham, MJG Farthing",Gut 44,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17998214557478804543,6,1999
Esophageal diseases,"RC Fitzgerald, MF Vaezi","Gastroenterology 154 (2), 263-266",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14305520997605158385,5,2018
Genomics of esophageal cancer and biomarkers for early detection,"M Pusung, S Zeki, R Fitzgerald","Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10001570117470347039,5,2016
Barrett metaplasia: reassessment of treatment and follow-up,RC Fitzgerald,"Current opinion in oncology 16 (4), 372-377",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3594585233863272057,5,2004
Machine learning and data mining frameworks for predicting drug response in cancer: An overview and a novel in silico screening process based on association rule mining,"K Vougas, T Sakelaropoulos, A Kotsinas, GRP Foukas, A Ntargaras, ...","Pharmacology & therapeutics, 107395",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1834110933150401676,4,2019
Early detection and therapeutics,"W Januszewicz, RC Fitzgerald","Molecular oncology 13 (3), 599-613",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6084352439375592126,4,2019
Interactions between genetic variants and environmental factors affect risk of esophageal adenocarcinoma and Barrett’s esophagus,"J Dong, DM Levine, MF Buas, R Zhang, L Onstad, RC Fitzgerald, ...","Clinical Gastroenterology and Hepatology 16 (10), 1598-1606. e4",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2236189885390346846,4,2018
Loss of SRY‐box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma,"FJC Ten Kate, SH van Olphen, MJ Bruno, BPL Wijnhoven, ...","British Journal of Surgery 104 (10), 1327-1337",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15264762685063664496,4,2017
Evolutionary dynamics in pre-invasive neoplasia,"C Abbosh, S Venkatesan, SM Janes, RC Fitzgerald, C Swanton","Current opinion in systems biology 2, 1-8",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=137792785423465303,4,2017
Dissecting out the genetic origins of Barrett’s oesophagus,RC Fitzgerald,"Gut 57 (8), 1033-1034",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14252430612997669045,4,2008
Gastrin-induced hyperproliferation in Barrett’s esophagus,"RC Fitzgerald, S Abdalla","Gastroenterology 125 (6), 1921",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14421455838949130255,4,2003
Characterisation of the inflammatory response in Barrett's eosophagus: Implications for the disease pathogenesis and its complications.,"RC Fitzgerald, B Onwuegbusi, IT Saaed, WR Burnham, MJG Farthing","Gastroenterology 116 (4), A158-A158",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6215554725384785952,4,1999
A clinically translatable hyperspectral endoscopy (HySE) system for imaging the gastrointestinal tract,"J Yoon, J Joseph, DJ Waterhouse, AS Luthman, GSD Gordon, M Di Pietro, ...","Nature communications 10 (1), 1902",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18149487447873688879,3,2019
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma,"RC Turkington, LA Knight, JK Blayney, M Secrier, R Douglas, EE Parkes, ...","Gut, gutjnl-2018-317624",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1485452590412703255,3,2019
Safety and acceptability of a non-endoscopic esophageal sampling device-Cytosponge®: a systematic review of multi-center data.,"W Januszewicz, WK Tan, K Lehovsky, I Debiram-Beecham, ...",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3217346007081712961,3,2018
Early Diagnosis of Gastroesophageal Cancers and the Cytosponge: A Work in Progress.,"RC Fitzgerald, BJ Reid","Cellular and molecular gastroenterology and hepatology 4 (3), 447-447",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17099186981598377317,3,2017
Application of a multi‐gene next‐generation sequencing panel to a non‐invasive oesophageal cell‐sampling device to diagnose dysplastic Barrett's oesophagus,"A Katz‐Summercorn, S Anand, S Ingledew, Y Huang, T Roberts, ...","The Journal of Pathology: Clinical Research 3 (4), 258-267",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8913903777974280890,3,2017
"Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance (vol 48, pg 1131, 2016)","M Secrier, X Li, N de Silva, MD Eldridge, G Contino, J Bornschein, ...",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13810188804876188215,3,2017
Signatures of mutational processes and associated risk factors in esophageal squamous cell carcinoma: a geographically independent stratification strategy?,"M Secrier, RC Fitzgerald","Gastroenterology 150 (5), 1080-1083",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17002900051870704377,3,2016
Combining simple patient-oriented tests with state-of-the-art molecular diagnostics for early diagnosis of cancer,RC Fitzgerald,"United European gastroenterology journal 3 (3), 226-229",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7610568075304916454,3,2015
Association of a DNA damage response deficiency (DDRD) assay and prognosis in early-stage esophageal adenocarcinoma.,"RC Turkington, LA Hill, D McManus, S McQuaid, K Arthur, J James, ...","Journal of Clinical Oncology 32 (15_suppl), 4015-4015",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9723211851881910658,3,2014
"56 Cytosponge Evaluation of Eosinophilic Esophagitis in Comparison to Endoscopy: Accuracy, Safety and Tolerability","DA Katzka, A Ravi, DM Geno, TC Smyrk, H Kita, P Lao-Sirieix, ...","Gastroenterology 146 (5), S-16",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6351134089820052836,3,2014
Testing the utility of an integrated analysis of copy number and transcriptomics datasets for inferring gene regulatory relationships,"XY Goh, R Newton, L Wernisch, R Fitzgerald","PloS one 8 (5), e63780",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12058853758516213538,3,2013
Phase 2 and phase 3 multicentre studies demonstrate the potential for glycans as predictive biomarkers in Barrett's oesophagus,"EL Bird-Lieberman, JM Dunn, P Lao-Sirieix, HG Mullholland, CE Moore, ...","Gut 60 (Suppl 1), A169-A170",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6129085562685940247,3,2011
"A Prospective, Multicenter Study to Evaluate a Novel, Nonendoscopic Screening Device for Barrett's Esophagus in the Community Setting","SR Kadri, P Lao–Sirieix, M O'Donovan, I Debiram–Beecham, M Das, ...","Gastroenterology 139 (1), e17",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6754391423237564065,3,2010
Medicaments for Treating Barrett's Eesophagus,"R Fitzgerald, CL Chang","US Patent App. 10/588,567",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4944568901105382877,3,2007
"Hereditary diffuse gastric cancer: Natural history, pathology, screening limitations, and prophylactic total gastrectomy in ","HT Lynch, C Caldas, D Wirtzfeld, C Vaccaro, W Rubinstein, S Weissman, ...","Journal of Clinical Oncology 25 (18_suppl), 4500-4500",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1899054358640762904,3,2007
Oesophageal and gastro-oesophageal junction tumours,"E Bird-Lieberman, R Fitzgerald","Medicine 35 (4), 199-203",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17843526289675745431,3,2007
Large-scale prospective study reveals novel risk factors for Barrett's oesophagus,"A Wong, LB Lovat, R Burnham, A Hackshaw, R Fitzgerald","WB SAUNDERS CO-ELSEVIER INC 132 (4), A254-A255",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13492328514124008108,3,2007
Surveillance and screening of Barrett's oesophagus,"P Lao-Sirieix, R Fitzgerald","British Journal of Hospital Medicine (2005) 67 (7), 355-359",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17149283181769055726,3,2006
Length of Barrett's oesophagus segment: Demographic associations and cancer risk,"PAC Gatenby, CPJ Caygill, A Watson, R Fitzgerald, A Charlett","Gastroenterology 124 (4), A638",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14298701188848876702,3,2003
Significance of acid exposure in Barrett's esophagus,RC Fitzgerald,"The American journal of gastroenterology 98 (3), 699",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7293595786097623550,3,2003
Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium (2017),"A Noorani, J Bornschein, AG Lynch, M Secrier, A Achilleos, M Eldridge, ...",A comparative analysis of whole genome sequencing of esophageal …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6538489762415700341,3,0
Barrett oesophagus,"Y Peters, A Al-Kaabi, NJ Shaheen, A Chak, A Blum, RF Souza, ...","Nature Reviews Disease Primers 5 (1), 1-22",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6022989156787461285,2,2019
High-fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett’s Esophagus via IL8 and Alterations to the Gut Microbiome,"NS Münch, HY Fang, J Ingermann, HC Maurer, A Anand, V Kellner, ...",Gastroenterology,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5792402609182452333,2,2019
A biomarker panel predicts progression of Barrett's esophagus to esophageal adenocarcinoma,"LC Duits, P Lao-Sirieix, WA Wolf, M O’Donovan, N Galeano-Dalmau, ...","Diseases of the Esophagus 32 (1), doy102",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4936178691006806449,2,2018
Quantitative phase and polarisation endoscopy applied to detection of early oesophageal tumourigenesis,"GSD Gordon, J Joseph, MP Alcolea, T Sawyer, AJ Macfaden, C Williams, ...",arXiv preprint arXiv:1811.03977,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15837426271431024423,2,2018
310-Efficacy of Cytosponge Directed Food Elimination Diet in Eosinophilic Esophagitis. a Pilot Trial,"JA Alexander, DA Katzka, K Ravi, RC Fitzgerald, DM Geno, C Tholen, ...","Gastroenterology 154 (6), S-76",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5658221230239135690,2,2018
Conference report: improving outcomes for gastrointestinal cancer in the UK,"I Forgacs, R Ashton, W Allum, T Bowley, H Brown, MP Coleman, ...","Frontline gastroenterology 9 (1), 49-61",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7982754375377798470,2,2018
OC-003 Feasibility and performance characteristics of a novel disposable transnasal capsule device for barrett’s oesophagusscreening: an international multicentre trial,"SS Sami, P Pophali, M Halland, MD Pietro, J Ortiz-Fernandez-Sordo, ...","Gut 66 (Suppl 2), A2-A2",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8813325039519147996,2,2017
Prognosis of oesophageal and gastro-oesophageal junctional cancer,"CJ Peters, C Caldas, RC Fitzgerald","US Patent 9,606,122",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1480850185738178472,2,2017
Barrett's oesophagus and oesophageal adenocarcinoma,"N De Silva, R Fitzgerald","Medicine 43 (4), 202-209",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5651919558785256609,2,2015
Biomarker for Barrett's Oesophagus,"P Lao-Sirieix, RC Fitzgerald","US Patent 8,709,736",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10689566186860420940,2,2014
Dysplasia and early neoplasia in Barrett's oesophagus,"M O'Donovan, R Fitzgerald","Diagnostic Histopathology 18 (10), 411-420",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11716779901964912152,2,2012
Cell sampling device,"RC Fitzgerald, SSR Kadri, P Lao-Sirieix","US Patent App. 13/509,035",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15509958309067361845,2,2012
Oracular guidance on clinical management of early neoplastic Barrett's esophagus,"RC Fitzgerald, JH Rubenstein","Gastroenterology 143 (2), 282-284",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2383638859619098621,2,2012
OC-008 Defining the genetic landscape of oesophageal adenocarcinoma by next-generation sequencing,"JMJ Weaver, NB Shannon, M Smith, M Dunning, CA Ong, C Ross-Innes, ...","Gut 61 (Suppl 2), A3-A4",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6138923026052282031,2,2012
OC-017 TRIM44: From prognosis to therapy in oesophageal adenocarcinoma and breast cancer,"CAJ Ong, NB Shannon, P Lao-Sirieix, C Ross-Innes, M O'Donovan, ...","Gut 61 (Suppl 2), A8-A8","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3524061189705334573,1649045397526892222",2,2012
Phase 3 Population-Based Study Reveals New Risk-Stratification Biomarker Panel for Barrett's Esophagus,"JM Dunn, EL Bird-Lieberman, P Lao-Sirieix, HG Mulholland, D Oukrif, ...","Gastroenterology 140 (5), S-136",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7588147709011310454,2,2011
Dietary fat intake in the aetiology of barrett's oesophagus and oesophageal adenocarcinoma: data from a prospective cohort study (EPIC-Norfolk) using 7-day food diary data,"M Yates, R Luben, E Cheong, L Igali, R Fitzgerald, KT Khaw, A Hart","Gut 60 (Suppl 1), A179-A179",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18229267606588041572,2,2011
Barrett’s oesophagus and oesophageal adenocarcinoma,"E Bird-Lieberman, H Ford, R Fitzgerald","Medicine 39 (3), 142-148",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15222327404674264579,2,2011
T1887 Development of Biomarkers for Non-Endoscopic Screening for Barrett's Esophagus,"SR Kadri, M Das, P Lao-Sirieix, M O'Donovan, I Debiram, RC Fitzgerald","Gastroenterology 136 (5), A-593-A-594",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6126646839964153775,2,2009
250 Characterisation of Squamous Oesophageal Epithelium and Location of Epithelial Stem Cells,"M Barbera, DP Doupe, AM Klein, BD Simons, PH Jones, RC Fitzgerald","Gastroenterology 136 (5), A-49",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=725042180645882051,2,2009
Biomarkers in Barrett's oesophagus and oesophageal adenocarcinoma,"AL Paterson, RC Fitzgerald","Expert opinion on medical diagnostics 1 (3), 363-376",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6179399717596651362,2,2007
Barrett's oesophagus: a clinical overview. Monitoring patients who are at risk of Oesophageal cancer,R Fitzgerald,"Gastrointestinal Nursing 3 (7), 27",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10284102498237226680,2,2005
The United Kingdom Barrett's Oesophagus Registry (UKBOR)-The first six years,"PI Reed, CPJ Caygill, A Watson, RC Fitzgerald","GASTROENTEROLOGIA POLSKA 10 (4), 299-304",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12994518866654281142,2,2003
National clinician scientist posts.,R Fitzgerald,"BMJ (Clinical research ed.) 325 (7366), S101-S101",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16500466852004986313,2,2002
Women in hospital medicine: career choices and opportunities,"RC Fitzgerald, C Black","Hospital Medicine 62 (12), 778-779",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=924292037359705586,2,2001
Beyond acid suppressants in gastro-oesophageal reflux disease,RC Fitzgerald,"Gut 49 (3), 320-321",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15628963663673278018,2,2001
Characterisation of intracellular ph control in barrett's esophagus: Evidence for an adaptive cellular response to gastro-esophageal reflux,"RC Fitzgerald, MJ Farthing, G Triadafilopoulos","Gastroenterology 118 (4), A223",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3462717110150322184,2,2000
Characterisation of the inflammatory response in Barrett's oesophagus: implications for the disease pathogenesis and its complications,"RC Fitzgerald, B Onwuegbusi, IT Saeed, WR Burnham, MJG Farthing",Gut 44,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11681553534040691238,2,1999
Bile salts induce or blunt cell proliferation in Barrett's esophagus in an acid-dependent fashion,"B Kaur, R Ouatu-Lascar, RC Fitzgerald, MB Omary","Gastroenterology 114, A170",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15087004077336522149,2,1998
Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases,"J An, P Gharahkhani, MH Law, JS Ong, X Han, CM Olsen, RE Neale, J Lai, ...","Nature communications 10 (1), 1-10",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7797378003045777318,1,2019
Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma,"TP Mourikis, L Benedetti, E Foxall, D Temelkovski, J Nulsen, J Perner, ...","Nature communications 10 (1), 1-17",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10224553193476648979,1,2019
No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study,"J Dong, P Gharahkhani, WH Chow, MD Gammon, G Liu, C Caldas, ...",Clinical Gastroenterology and Hepatology,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17622798593855757472,1,2019
MUC16 mutations and prognosis in gastric cancer: a little goes a long way,"EC Smyth, RC Fitzgerald","JAMA oncology 4 (12), 1698-1699",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13546502178642047820,1,2018
Screening for Barrett’s Esophagus: Are New High-Volume Methods Feasible?,"M O’Donovan, RC Fitzgerald","Digestive diseases and sciences 63 (8), 2105-2114",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=868175401101232770,1,2018
Patient-specific detection of cancer genes reveals recurrently perturbed processes in esophageal adenocarcinoma,"TP Mourikis, L Benedetti, E Foxall, J Perner, M Cereda, J Lagergren, ...","bioRxiv, 321612",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8443805589739719309,1,2018
Cancer development: Origins in the oesophagus,"L Zhuang, RC Fitzgerald","Nature 550 (7677), 463",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8111517209798573085,1,2017
"What John Shirley Said About Adam: Authorship and Attribution in Cambridge, Trinity College, MS R. 3.20",M Connolly,The Dynamics of the Medieval Manuscript,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5320680610917386750,1,2017
A comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status,"R Fitzgerald, M Tischkowitz, M Di Pietro, M O'Donovan, S Richardson, ...",Elsevier,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11860829179543870099,1,2017
PD-L1 expression and response to neo-adjuvant chemotherapy in esophageal adenocarcinoma.,"EE Parkes, JK Blayney, E McCarron, RV Douglas, L Stevenson, ...","Journal of Clinical Oncology 35 (15_suppl), 4023-4023",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1842610611987740198,1,2017
538 Feasibility and Performance Characteristics of a Novel Disposable Transnasal Capsule Device for Barrett's Esophagus Screening: A Prospective International Multicenter Trial,"P Pophali, S Sarmed, M Halland, M DiPietro, F Enders, ...","Gastrointestinal Endoscopy 85 (5), AB77",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7743198528917974867,1,2017
"Decision making, quality of life and prophylactic gastrectomy in carriers of pathogenic CDH1 mutations","G Roberts, R Hardwick, RC Fitzgerald",Translational gastroenterology and hepatology 2,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17466594288914925654,1,2017
Leadership roles for women in gastroenterology: New initiatives for the new generation of gastroenterologists.,"J Moleiro, M Ilie, R Fitzgerald","United European gastroenterology journal 4 (6), 815-815",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16310115149906098781,1,2016
A multicentre cohort study to redefine and validate pathological assessment of response to neoadjuvant therapy in treated oesophagogastric adenocarcinoma,"MA Lloyd, F Noble, R Walker, D McManus, R Turkington, M Bedford, ...","European Journal of Surgical Oncology 42 (11), S252",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4559011891392123703,1,2016
Screening for Barrett esophagus with a nonendoscopic sponge capsule,R Fitzgerald,"Gastroenterology & hepatology 11 (9), 623",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15675061328826311072,1,2015
PTU-145 Prophylactic total gastrectomy for hereditory gastric cancer syndrome,"F Rashid, C Suo, B Tan, S Richardson, R Fitzgerald, M Di Pietro, ...","Gut 64 (Suppl 1), A126-A126",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17099906907135468182,1,2015
OC-016 The Toll-like Receptor Pathway Is Recurrently Mutated In Oesophageal Adenocarcinoma,"DRF Elliott, CS Ross-Innes, MD Eldridge, RC Fitzgerald","Gut 63 (Suppl 1), A8-A8","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16496012625518260536,1206792245519264309",1,2014
Sa1924 Utility of a Biomarker Panel to Predict Progression to Esophageal Adenocarcinoma in Barrett's Esophagus,"WA Wolf, P Lao-Sirieix, LC Duits, A Chak, NJ Shaheen, R Fitzgerald, ...","Gastroenterology 146 (5), S-330",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=526576631708637988,1,2014
540 Biomarkers for Early Detection of Esophageal Squamous Cell Dysplasia and Carcinoma,"JE Redman, R Newton, S Malhotra, SM Dawsey, L Wernisch, ...","Gastroenterology 146 (5), S-96",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2012317881942868884,1,2014
"Barrett's oesophagus: diagnosis, surveillance and treatment","J Bornschein, RC Fitzgerald","British Journal of Hospital Medicine (2005) 74 (8), 444-450",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17314630998173092645,1,2013
PTU-154 Sirt2 modulates the inflammatory response in oesophageal adenocarcinoma,"LKE Schulz, P Lao-Sirieix, M O’Donovan, RC Fitzgerald","Gut 62 (Suppl 1), A111-A111",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10497108854286068485,1,2013
PWE-164 Utilizing Integrative Genomic Analysis and Proteomics to Decipher the Biology and Therapeutic Potential of Trim44 in Oesophageal Adenocarcinoma and Breast Cancer,"JC Ong, N Shannon, J Skehel, K Wang, OM Rueda, CE Walker, ...","Gut 62 (Suppl 1), A197-A197",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3155392891419544716,1,2013
PTU-156 The Combination of Autofluorescence Imaging and Probe-Based Confocal Laser Endomicroscopy has an Excellent Diagnostic Accuracy for Dysplasia in Barrett’S Esophagus,"M Di Pietro, E Bird-Lieberman, X Liu, M O’Donovan, RC Fitzgerald","Gut 62 (Suppl 1), A111-A112","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7165972081606111045,785119380522666122",1,2013
Sa1992 SFRS2 and CDC5L interaction: an insight into downstream events following APC deletion during colorectal carcinogenesis,"SA Ibrahim, KR Reed, AR Clarke, DM Pritchard, JR Jenkins","Gastroenterology 144 (5), S-353-S-354",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13147801494377389287,1,2013
Sa1984 Lewis Biomarkers for Detection of Dysplasia in Barrett's Esophagus,"EL Bird-Lieberman, M O'Donovan, P Lao-Sirieix, L Lovat, R Fitzgerald","Gastroenterology 144 (5), S-352",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14953089539749792712,1,2013
644 Defining Cancer Risk in Barrett's Esophagus Using a 90-Gene Signature,"S Varghese, R Newton, C Ross-Innes, P Lao-Sirieix, M O'Donovan, ...","Gastroenterology 144 (5), S-113-S-114","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1370182123395389453,15431099664034959472",1,2013
640 Epigenetically Regulated Hoxb Cluster Genes Have a Functional Role in Barrett's Esophagus Development,"M di Pietro, P Lao-Sirieix, S Boyle, A Cassidy, A Saadi, D Castillo, ...","Gastroenterology 142 (5), S-127",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7355704472854093072,1,2012
* Image cytometry DNA ploidy abnormalities are an independent risk factor for cancer progression in non-dysplastic barrett's oesophagus and low grade dysplasia: results of the …,"JM Dunn, EL Bird-Lieberman, HG Coleman, D Oukrif, K Arthur, ...","Gut 60 (Suppl 1), A172-A173",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5891574319986344065,1,2011
Trimodal imaging to identify microscopic foci of signet ring cells in hereditary diffuse gastric cancer,"YC Lim, I Debiram, M O'Donovan, S Richardson, S Dwerryhouse, ...","Gut 60 (Suppl 1), A192-A193",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5157860928351821705,1,2011
Phase Ib trial of lapatinib oxaliplatin and capecitabine in early HER2-overexpressing esophagogastric cancer.,"H Ford, D Hochhauser, A Paterson, L Lovat, M Jobanputra, RC Fitzgerald","Journal of Clinical Oncology 28 (15_suppl), TPS339-TPS339",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11453151440439242232,1,2010
511a: Nasal or Standard Endoscopy (NOSE) for Diagnosis of Barrett's Oesophagus-Efficacy and Patient Tolerance,"KM Shariff, EL Bird-Lieberman, SL Vowler, Z Abdullahi, M O'Donovan, ...","Gastrointestinal Endoscopy 71 (5), AB121",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13488351793171411145,1,2010
T1877 A Pilot Feasibility Study of Screening for Barrett's Esophagus with a Novel Non-Endoscopic Capsule Sponge Device in a Primary Care Setting Device in a Primary Care Setting,"SR Kadri, I Debiram, P Lao-Sirieix, M O'Donovan, JM Blazeby, A Males, ...","Gastroenterology 136 (5), A-591","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9286495453273956542,18020060022932755479",1,2009
"The definition and management of Barrett’s oesophagus: a case report, review of the literature and a suggestion for the future","EL Bird-Lieberman, P Lao-Sirieix, I Saeed, D Khoo, R Burnham, ...","BMJ case reports 2009, bcr0720080450",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12783668439072332768,1,2009
206 A ROLE FOR NITRIC OXIDE IN THE INVASIVE PROCESS IN OESOPHAGEAL ADENOCARCINOMA,"NJ Clemons, R Abeyratne, N Shannon, RC Fitzgerald",Gut 56,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13074176070344840722,1,2007
Mechanisms underlying the progression of Barrett's oesophagus,"A Saadi, RC Fitzgerald","Drug Discovery Today: Disease Mechanisms 3 (4), 447-456",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16544761606490260663,1,2006
Development and evaluation of a non-endoscopic immunocytological screening test for Barrett's esophagus,"P Lao-Sirieix, M O'Donovan, S Gardiner, I Debiram, RC Fitzgerald","Journal of Clinical Gastroenterology 40, S191",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1057096532451704052,1,2006
Cyclin a immunocytology as a risk stratification tool in Barrett's Esophagus surveillance,"P Lao-Sirieix, L Lovat, RC Fitzgerald","WB SAUNDERS CO-ELSEVIER INC 130 (4), A7-A7","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16904208038795840287,157691751156004164",1,2006
三种食管鳞癌细胞系的染色体异常研究,李晓昀， 苏敏,"中国癌症杂志 15 (5), 446-449",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5044194323415945845,1,2005
Gastrin induces cyclooxygenase (COX)-2 expression in Barrett's oesophagus,"S Abdalla, PS Sirieix, IR Sanderson, RC Fitzgerald","Gut 53 (4), A58-A58",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1312368789257222111,1,2004
Dual role of TGF beta in the initiation and progression of Barrett's associated oesophageal adenocarcinoma,"BA Onwuegbusi, RC Fitzgerald","Gastroenterology 126 (4), A546-A547",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3284631146784456029,1,2004
In vitro induction and reversal of premalignant Barrett's oesophagus by manipulation of retinoic acid pathways,"CL Chang, P Sirieix, V Save, R Laskey, R Fitzgerald","Gastroenterology 126 (4), A46-A47",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1589533541712961022,1,2004
Impairment of TGF beta signalling in Barrett's associated oesophageal adenocarcinoma: Role of Smad4,"BA Onwuegbusi, RC Fitzgerald","Gut 52, A44-A44",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1632319781314351603,1,2003
Cyclooxygenase-2 expression in columnar versus squamous phenotypes: Relationship to oesophageal inflammation and Barrett's oesophagus,"SI Abdalla, IR Sanderson, RC Fitzgerald","Gastroenterology 122 (4), A290-A291",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12019049887092508149,1,2002
Significance of genetic abnormalities after photodynamic therapy,"RC Fitzgerald, L Lovat","Gastroenterology 120 (4), 1064-1065",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9824887136219593904,1,2001
Inflammation at the neo squamo-columnar junction in Barrett's oesophagus,RC Fitzgerald,"Gut 47 (6), 870-870",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=570449085101914004,1,2000
Normalization of intraesophageal pH enhances differentiation and decreases proliferation in Barrett's esophagus,"R Ouatu-Lascar, RC Fitzgerald, MB Omary, G Triadafilopoulos","Gastroenterology 114, A660-A661",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13908252511623984310,1,1998
Barrett's cancer cells (TE7) provide a potential mechanism for the proliferative response to acid in Barrett's metaplasia and cancer.,"RC Fitzgerald, MB Omary, T Nishihira, G Triadafilopoulos","Gastroenterology 112 (4), A561-A561",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4697234120735229058,1,1997
A Deep Learning Framework for Predicting Response to Therapy in Cancer,"T Sakellaropoulos, K Vougas, S Narang, F Koinis, A Kotsinas, A Polyzos, ...","Cell Reports 29 (11), 3367-3373. e4",,0,2019
Role of TFF3 as an adjunct in the diagnosis of Barrett's esophagus using a minimally invasive esophageal sampling device—The CytospongeTM,"AL Paterson, M Gehrung, RC Fitzgerald, M O'Donovan",Diagnostic Cytopathology,,0,2019
Development and validation of a risk prediction model to diagnose Barrett's oesophagus (MARK-BE): a case-control machine learning approach,"A Rosenfeld, DG Graham, S Jevons, J Ariza, D Hagan, A Wilson, SJ Lovat, ...",The Lancet Digital Health,,0,2019
Development and External Validation of a MAchine learning RisK prediction model as a pre-screening tool to diagnose Barrett’s Oesophagus,R Fitzgerald,Elsevier,,0,2019
Genomic evidence supports a clonal diaspora model for metastases of esophageal 1 adenocarcinoma,R Fitzgerald,Springer Nature,,0,2019
Quantitative phase and polarization imaging through an optical fiber applied to detection of early esophageal tumorigenesis,"GSD Gordon, J Joseph, MP Alcolea, T Sawyer, C Williams, ...","Journal of Biomedical Optics 24 (12), 126004",,0,2019
Time to Challenge Current Strategies for Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma,"DA Katzka, RC Fitzgerald","Digestive diseases and sciences, 1-4",,0,2019
Association Between Levels of Hormones and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus,"SH Xie, R Fang, M Huang, J Dai, AP Thrift, LA Anderson, WH Chow, ...",Clinical Gastroenterology and Hepatology,,0,2019
Comparison of Phenotypes and Risk Factors for Esophageal Adenocarcinoma at Present vs Prior Decades,"T Sawas, N Azad, S Killcoyne, PG Iyer, KK Wang, RC Fitzgerald, ...",Clinical Gastroenterology and Hepatology,,0,2019
Machine learning to predict early recurrence after oesophageal cancer surgery,"S Rahman, R Walker, M Lloyd, B Grace, G van Boxel, BF Kingma, ...","European Journal of Surgical Oncology 45 (11), 2212",,0,2019
Inhibition of Notch signalling in gastric epithelial cells in response to Helicobacter pylori infection,"R Fitzgerald, H Windle, D Kelleher, D McNamara, S Smith","EUROPEAN JOURNAL OF IMMUNOLOGY 49, 1142-1143",,0,2019
European Landscape of CDH1 germline mutations: a new tool to understand hereditary diffuse gastric cancer (HDGC),"J Garcia Pelaez, A Monteiro, L Sousa, S Castedo, L Garrido, G Michils, ...","EUROPEAN JOURNAL OF HUMAN GENETICS 27, 1126-1128",,0,2019
822P Assessing the clinical utility of circulating tumour DNA through longitudinal liquid biopsy sampling in oesophageal adenocarcinoma,"E Ococks, A Frankell, N Masque-Soler, A Northrop, G Devonshire, ...","Annals of Oncology 30 (Supplement_5), mdz247. 148",,0,2019
173TiP Cambridge liquid biopsy “CALIBRATION” study: Can changes in circulating tumour DNA (ctDNA) predict durable tumour responses in patients with advanced oesophageal cancer …,"C Linossi, A Williams, R Baird, S Dovedi, R Fitzgerald, S Pacey","Annals of Oncology 30 (Supplement_5), mdz239. 080",,0,2019
Patient symptom experience prior to a diagnosis of oesophageal or gastric cancer: a multi-methods study,"E Humphrys, F Walter, G Rubin, JD Emery, M Johnson, A Richards, ...",Royal College of General Practitioners,,0,2019
423 Type 2 Immunity Linked to iRhom2 and Tylosis with Oesophageal Cancer,"S Murtough, CM Webb, A Chikh, HL dit Picard, R Pink, J Wang, ...","Journal of Investigative Dermatology 139 (9), S287",,0,2019
P-210 Cytosponge™ for post‐chemoradiation surveillance of oesophageal cancer: a feasibility study,"S Levy, J Moschandreas, I Debiram-Beecham, M O’Donovan, C Brooks, ...","Annals of Oncology 30 (Supplement_4), mdz155. 209",,0,2019
Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study,"Y Xu, A Miremadi, A Link, P Malfertheiner, RC Fitzgerald, J Bornschein","Journal of Clinical Pathology, jclinpath-2019-205700",,0,2019
A MACHINE LEARNING-BASED MODEL TO PREDICT THE PRESENCE OF BARRETT’S OESOPHAGUS: OTU-16,"L Lovat, S Sami, D Graham, J Ariza, D Hagan, F Ocampo, M Novelli, ...",Gut 68,,0,2019
OTU-16 A machine learning-based model to predict the presence of barrett’s oesophagus,"L Lovat, S Sami, D Graham, J Ariza, D Hagan, F Ocampo, M Novelli, ...","Gut 68 (Suppl 2), A133",,0,2019
OTU-17 Methylation panel in the assessment of clinical response to the radio-frequency ablation for barrett’s oesophagus,"W Januszewicz, W Waldock, VV Subhash, D Fernando, G Bartalucci, ...","Gut 68 (Suppl 2), A133",,0,2019
Landscape of innate and adaptive immunity targets in oesophagogastric adenocarcinoma (OGA).,"EC Smyth, C Linossi, S Jammula, G Devonshire, RC Fitzgerald","Journal of Clinical Oncology 37 (15_suppl), 4063-4063",,0,2019
"Ingested asbestos in filtered beer, in addition to occupational exposure, as a causative factor in oesophageal adenocarcinoma","RC Fitzgerald, JM Rhodes","British journal of cancer, 1",,0,2019
Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction,"J Bornschein, L Wernisch, M Secrier, A Miremadi, J Perner, S MacRae, ...",International journal of cancer,,0,2019
Su2042–Derivation of Oesophageal Organoids to Recapitulate the Heterogeneity of Primary Tumours and Provide a Model System for Precision Therapeutics,"X Li, H Francies, A Miremadi, A Grantham, N Grehan, G Devonshire, ...","Gastroenterology 156 (6), S-696",,0,2019
Sa1147–Analysis of Socio-Economic Factors Affecting the Uptake of the Novel Medical Device Cytosponge,"M Gehrung, B De Quadros, Z Khan, F Markowetz, I Debiram-Beecham, ...","Gastroenterology 156 (6), S-284-S-285",,0,2019
Sa1163–The Risk of Prevalent and Incident Neoplasia in Patients with a Diagnosis of Barrett's Esophagus Indefinite for Dysplasia,"W Januszewicz, R Phillips, M O'Donovan, RC Fitzgerald, M Di Pietro","Gastroenterology 156 (6), S-291",,0,2019
1067–A Machine Learning-Based Model to Predict the Presence of Barrett's Esophagus,"L Lovat, SS Sami, DG Graham, S Jevons, VO Eneh, J Ariza, DA Hagan, ...","Gastroenterology 156 (6), S-222",,0,2019
454 iRhom2-mediated immune dysregulation: Impact on the skin and oesophagus,"C Webb, S Murtough, A Chikh, HL dit Picard, J Wang, R Pink, JM Risk, ...","Journal of Investigative Dermatology 139 (5), S78",,0,2019
Barrett's oesophagus and oesophageal adenocarcinoma,"W Januszewicz, RC Fitzgerald",Medicine,,0,2019
Will a Proton Pump Inhibitor and an Aspirin Keep the Doctor Away for Patients With Barrett’s Esophagus?,"RC Fitzgerald, DA Corley","Gastroenterology 156 (5), 1228-1231",,0,2019
A sinister black finding in the stomach,"W Januszewicz, P Corrie, H Liu, J Chan, RC Fitzgerald, M Di Pietro","The Lancet 393 (10176), 1149",,0,2019
Multispectral endoscopy for early detection of dysplasia in Barrett’s oesophagus (MuSE): a pilot study (Conference Presentation),"DJ Waterhouse, S Luthman, M di Pietro, W Januszewicz, RC Fitzgerald, ...",Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems …,,0,2019
Image Analysis of Esophageal Biopsies and Cytosponge Specimens Stained for Eosinophil Peroxidase Identifies Subjects with Eosinophilic Esophagitis,"SM Barshow, KP Shim, TS Smyrk, DM Geno, AD Doyle, EA Jacobsen, ...","Journal of Allergy and Clinical Immunology 143 (2), AB310",,0,2019
"Examining the effects of BET, HDAC2, and EZH2 inhibition on esophageal adenocarcinoma (EAC) cell line proliferation.","K Kofonikolas, AM Frankell, EC Smyth, RC Fitzgerald","Journal of Clinical Oncology 37 (4_suppl), 68-68",,0,2019
"Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1 (vol 6, 32417, 2016)","E Garcia, A Hayden, C Birts, E Britton, C Rogerson, CW Bleaney, A Cowie, ...",Scientific Reports 9,,0,2019
Author Correction: Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1,"E Garcia, A Hayden, C Birts, E Britton, C Rogerson, CW Bleaney, A Cowie, ...","Scientific reports 9 (1), 318",,0,2019
Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data from Individual Patients,RC Fitzgerald,Elsevier,,0,2019
Pan-cancer analysis of whole genomes reveals driver rearrangements promoted by LINE-1 retrotransposition in human tumours,RC Fitzgerald,Springer Nature,,0,2019
Shared genetic etiology of obesity-related traits and Barrett's esophagus/adenocarcinoma: Insights from genome-wide association studies,"AC Böhmer, J Hecker, J Schröder, P Gharahkhani, A May, C Gerges, ...",Cancer Epidemiology and Prevention Biomarkers,,0,2019
"Lung, spleen and oesophagus tissue remains stable for scRNAseq in cold preservation","E Madissoon, A Wilbrey-Clark, RJ Miragaia, K Saeb-Parsy, K Mahbubani, ...","bioRxiv, 741405",,0,2019
DNA Methylation Biomarkers for the Diagnosis of Barrett’s Oesophagus,"C Kosmidou, S Jammula, RC Fitzgerald","The American journal of gastroenterology 113 (11), 1722",,0,2018
Exploring germline variation in known cancer predisposing genes amongst CDH1-negative hereditary diffuse gastric cancer families,"ER Fewings, A Larionov, J Redman, M Goldgraben, R Hardwick, ...","EUROPEAN JOURNAL OF HUMAN GENETICS 26, 570-571",,0,2018
A crosssectional analysis of Facebook comments to study public perception of a new diagnostic test called the Cytosponge,"WK Tan, B Muldrew, Z Khan, RC Fitzgerald","Diseases of the Esophagus 32 (1), doy085",,0,2018
Methods and means for dysplasia analysis,"RC Fitzgerald, S Varghese, R Newton, L Wernisch","US Patent App. 15/747,117",,0,2018
Early detection of esophageal adenocarcinoma using near-infrared lectin-based imaging,"AA Neves, M Di Pietro, M O'Donovan, DJ Waterhouse, SE Bohndiek, ...","Cancer Research 78 (13 Supplement), 3600-3600",,0,2018
Organ-preserving approaches in oesophageal cancer.,RC Fitzgerald,"The Lancet. Oncology 19 (7), 858-859",,0,2018
OWE-036 Implementation of cytospongetm device training for nurses in primary care,"ID Beecham, B Alias, T Nuckcheddy, B Bowers, L Murray, A Wilson, ...","Gut 67 (Suppl 1), A269-A269",,0,2018
Tu1119-Efficacy of Cytosponge to Assess for Recurrent or Residual Barrett's Esophagus Following Endoscopic Eradication Therapy,"S Eluri, A Paterson, M O'Donovan, P Bhandari, M Di Pietro, R Haidry, ...","Gastroenterology 154 (6), S-897",,0,2018
Sa1643-Feasibility of the Implementation of Cytosponge as a Triage Test for Reflux Symptoms in Primary Care: Barrett's Esophagus Screening Trial 3 (Best3),"A Wilson, I Debiram-Beecham, B Bowers, B Muldrew, B Aigret, ...","Gastroenterology 154 (6), S-339",,0,2018
BIOMARKER FOR BARRETT'S OESOPHAGUS,"P Lao-sirieix, RC Fitzgerald","US Patent App. 15/465,298",,0,2018
Clonal Diaspora in Metastatic Esophageal Adenocarcinoma Describes a New Model of Cancer Progression,"A Noorani, M Goddard, J Crawte, LB Alexandrov, M Secrier, MD Eldridge, ...",,,0,2018
Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma,"A Noorani, M Goddard, J Crawte, LB Alexandrov, X Li, M Secrier, ...","bioRxiv, 454306",,0,2018
Process-specific somatic mutation distributions vary with three-dimensional genome structure,"KC Akdemir, VT Le, S Killcoyne, DA King, YP Lin, Y Tian, A Inoue, S Amin, ...","bioRxiv, 426080",,0,2018
Low-cost and clinically applicable copy number profiling using repeat DNA,"S Abujudeh, SS Zeki, MCV van Lanschot, M Pusung, JMJ Weaver, X Li, ...","bioRxiv, 394429",,0,2018
Development of innervation in primary incisors in the foetal period,"P Ong, R Skittrall, S Abramowicz, M Cooper, K Bardi, R Weyant, ...","Gastrointestinal Nursing 134 (Suppl 3), 1-14",,0,2017
"A non-endoscopic device to sample the oesophageal microbiota: a case-control study (vol 2, pg 32, 2017)","FDR Elliott, AW Walker, M O'Donovan, J Parkhill, RC Fitzgerald","LANCET GASTROENTEROLOGY & HEPATOLOGY 2 (11), E7-E7",,0,2017
High-risk individuals’ perceptions of reproductive genetic testing for CDH1 mutations,"N Hallowell, S Badger, S Richardson, C Caldas, RH Hardwick, ...","Familial cancer 16 (4), 531-535",,0,2017
Serological screening for upper gastrointestinal adenocarcinoma risk-The SUGAR study,"J Bornschein, Y Xu, A Miremadi, A Link, P Malfertheiner, RC Fitzgerald",HELICOBACTER 22,,0,2017
PWE-108 Staining and dysplasia status in barrett’s oesophagus; a retrospective study,"A Corovic, A Miremadi, RC Fitzgerald","Gut 66 (Suppl 2), A181-A181",,0,2017
Assessment of conditional survival probability in resected esophageal adenocarcinoma.,"DM Graham, F Bannon, M Lloyd, F Noble, R Walker, E Griffiths, M Bedford, ...","Journal of Clinical Oncology 35 (15_suppl), 4030-4030",,0,2017
Biomarker for Barrett's Oesophagus,"P Lao-Sirieix, RC Fitzgerald","US Patent 9,632,099",,0,2017
Medicine is the ultimate personalised technology,"RC Fitzgerald, P Sasieni","Bmj 357, j1750",,0,2017
Detoxification loss drives aldehydemetabolic reprogramming and contributes to genotoxicity in oesophageal adenocarcinoma,"S Antonowicz, Z Bodai, T Wiggins, S Markar, P Boshier, H Kudo, F Rosini, ...","BRITISH JOURNAL OF SURGERY 104, 46-46",,0,2017
The Cytosponge is a Safe and Well-Tolerated Method of Sampling Esophageal Tissue in Patients with Eosinophilic Esophagitis,"AO Chang, DA Katzka, DM Geno, T Smyrk, RM Beitia, JA Alexander, ...","Gastroenterology 152 (5), S207-S208",,0,2017
Analysis of Structural Variants in Esophageal Adenocarcinoma Reveals Multiple Hits in Cell-Cell Communication Pathways,"G Contino, MD Secrier, S Abbas, M Eldridge, L Bower, PA Edwards, ...","Gastroenterology 152 (5), S126",,0,2017
Acceptability of Tissue Collection by Cytosponge in US Patients with Barrett's Esophagus,"AO Chang, CC Cotton, S Eluri, A Guthikonda, RD Madanick, RM Beitia, ...","Gastroenterology 152 (5), S457",,0,2017
Shallow Whole Genome Sequencing can Detect Copy Number Changes in FFPE Material in the Progression of Barrett's Esophagus,"E Gregson, S Killcoyne, D Wedge, M Eldridge, A Miremadi, K Jenkins, ...","Gastroenterology 152 (5), S106",,0,2017
Whole-genome sequencing analysis of structural variants in oesophageal adenocarcinoma,"G Contino, M Secrier, PAW Edward, R Fitzgerald","The Lancet 389, S34",,0,2017
Large scale meta-analysis identifies new genetic risk loci for esophageal adenocarcinoma (EA) and the first EA risk locus independent of Barrett’s esophagus,"P Gharahkhani, RC Fitzgerald, TL Vaughan, I Tomlinson, I Gockel, ...",Nature Genetics,,0,2017
Profiling Toll-Like Receptor Pathway Mutations and Expression in Esophageal Adenocarcinoma,"DRF Elliott, J Perner, MF Symmons, B Verstak, X Li, M O'Donovan, ...","LABORATORY INVESTIGATION 97, 456A-456A",,0,2017
"Use of a non-endoscopic device to sample the oesophageal microbiota: a case-control study (vol 2, pg 32, 2017)","FDR Elliott, AW Walker, M O'Donovan, J Parkhill, RC Fitzgerald","LANCET GASTROENTEROLOGY & HEPATOLOGY 2 (1), E1-E1",,0,2017
Major advances in gastroenterology and hepatology over the last 25 Years: Review of 25th UEG Week Anniversary Session,"M Farthing, J Panes, M Manns, J Atherton, P Fockens, S Koletzko, ...","United European gastroenterology journal 5 (7), 1053-1056",,0,2017
Correction to Lancet Gastroenterol Hepatol,"DR Fels Elliott, AW Walker, M O’Donovan, J Parkhill, RC Fitzgerald","Gastroenterol Hepatol 2, 785-92",,0,2017
Loss of SRY-box2 (SOX2) expression predicts adverse survival of patients with esophageal adenocarcinoma,"FJC ten Kate, SH van Olphen, MJ Bruno, BPL Wijnhoven, ...",Advances in Barrett’s Esophagus Surveillance and Improved Prediction of …,,0,2017
Association of a DNA Damage Response Deficiency (DDRD) Assay with Prognosis in Resected Esophageal and Gastric Adenocarcinoma,"RC Turkington, L Knight, R Douglas, L Stevenson, D McManus, ...","Age 222, 51",,0,2017
IRES-Mediated Protein Translation Overcomes Suppression by the p14ARF Tumor Suppressor Protein,"S Xi, M Zhao, S Wang, L Ma, S Wang, X Cong, RA Gjerset, RC Fitzgerald, ...","Journal of Cancer 8 (6), 1082",,0,2017
Leadership roles for women in gastroenterology: New initiatives for the new generation of gastroenterologists Late-breaking abstracts,"M Ilie, R Fitzgerald","UNITED EUROPEAN GASTROENTEROLOGY JOURNAL 4 (6), 815-815",,0,2016
Towards the next-generation of cancer cell lines: Derivation of an organoid biobank,"H Francies, C Middleton, R Barber, J Gilbert, L Letchford, S Valentini, ...","European Journal of Cancer 69, S58",,0,2016
A non-endoscopic sampling device to sample the oesophageal microbiota: a case-control study,"DRF Elliott, AW Walker, M O’Donovan, J Parkhill, RC Fitzgerald",Elsevier,,0,2016
Incidence and progression of Barrett's oesophagus in clinical practice: A cohort analysis for planning of the Barrett's ESophagus Trial 3 (BEST3) comparing the Cytosponge-TFF3 …,"J Offman, F Pesola, R Fitzgerald, W Hamilton, P Sasieni","European Journal of Surgical Oncology 42 (11), S252-S253",,0,2016
A comparison of the yield from endoscopic surveillance in detecting early gastric cancer in CDH1+ ve versus CDH1− ve HDGC families,"E Mi, E Mi, M Tischkowitz, S Richardson, M di Pietro, K Ragunath, ...","European Journal of Surgical Oncology 42 (11), S246-S247",,0,2016
Conditional survival probability in patients with resected oesophageal adenocarcinoma receiving neoadjuvant chemotherapy,"DM Graham, FJ Bannon, F Noble, R O'Neill, JK Blayney, TJ Underwood, ...",Annals of Oncology 27 (suppl_6),,0,2016
SOX2 loss predicts adverse survival in esophageal adenocarcinoma patients,"F ten Kate, S van Olphen, M Bruno, B Wijnhoven, J van Lanschot, ...","VIRCHOWS ARCHIV 469, S2-S2",,0,2016
"A new, biologically relevant classification for adenocarcinoma at the gastroesophageal junction","J Bornschein, J Perner, L Wernisch, M Secrier, S MacRae, A Miremadi, ...",29th International Workshop on Helicobacter and Microbiota in Inflammation …,,0,2016
A multicentre cohort study to redefine and validate pathological assessment of response to neoadjuvant therapy in treated oesophagogastric adenocarcinoma,"F Noble, M Lloyd, R Walker, R Turkington, D McManus, M Bedford, ...","BRITISH JOURNAL OF SURGERY 103, 41-42",,0,2016
Germline genetic variants and risk of Barrett's esophagus and esophageal adenocarcinoma: a large scale meta-analysis of genome-wide association studies,"CL Palles, I Tomlinson, L Chegwidden, P Gharahkhani, S MacGregor, ...",Lancet Oncology 17 (10),,0,2016
cell lines [version 1; referees: 3 approved],"G Contino, MD Eldridge, M Secrier, L Bower, RF Elliott, J Weaver, ...",,,0,2016
Whole-genome sequencing of nine esophageal adenocarcinoma cell lines [version 1; referees: 3 approved],"G Contino, MD Eldridge, M Secrier, L Bower, RF Elliott, J Weaver, ...",,,0,2016
Large scale meta-analysis identifies new genetic risk loci for esophageal adenocarcinoma (EA) and the first EA risk locus independent of Barrett’s esophagus,"C Palles, I Tomlinson, L Chegwidden, P Gharahkhani, S MacGregor, ...",Lancet Oncology 17 (10),,0,2016
OC-053 Lectin-Based Near infra-red Molecular Imaging for Dysplasia Detection in Barrett’s Oesophagus: An ex-vivo Study on Human Tissue,"M Di Pietro, A Neves, M O’Donovan, D Waterhouse, S Bohndiek, ...","Gut 65 (Suppl 1), A30-A31",,0,2016
PWE-069 Sampling Oesophageal Microbial Communities in Barrett's Oesophagus Using Minimally Invasive and Endoscopic Methods,"DRF Elliott, AW Walker, M O'Donovan, J Parkhill, RC Fitzgerald, ...","Gut 65, A172",,0,2016
Tu2054 Siewert Type Does Not Reflect Cancer Biology at the Gastro-Esophageal Junction,"J Bornschein, M Secrier, L Wernisch, R Newton, J Perner, S MacRae, ...","Gastroenterology 150 (4), S1011",,0,2016
Design and validation of a near-infrared fluorescence endoscope for detection of early esophageal malignancy using a targeted imaging probe,"DJ Waterhouse, J Joseph, AA Neves, M di Pietro, KM Brindle, ...",Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems …,,0,2016
Method and apparatus of aiding detection of surface abnormality in the oesophagus,"R Fitzgerald, RI Caryn","US Patent App. 14/768,740",,0,2016
Whole-genome sequencing of nine esophageal adenocarcinoma cell lines,"C Gianmarco, MD Eldridge, M Secrier, L Bower, ER Fels, J Weaver, ...",F1000Research 5,,0,2016
"Erratum to: Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future.","I Gullo, C Oliveira, LH Tang, HI Grabsch, M O'Donovan, RC Fitzgerald, ...","Advances in experimental medicine and biology 908, E1-E1",,0,2016
Genetics and Biomarkers in Barrett’s Esophagus and Esophageal Adenocarcinoma,"AC Katz-Summercorn, AM Frankell, RC Fitzgerald","Barrett's Esophagus, 37-60",,0,2016
"Erratum to: Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future","RS van der Post, I Gullo, C Oliveira, LH Tang, HI Grabsch, M O’Donovan, ...","Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal …",,0,2016
Molecular biology of Barrett’s esophagus and esophageal adenocarcinoma,"A Noorani, RC Fitzgerald","Esophageal cancer and barrett's esophagus, 55-68",,0,2015
Autofluorescence-directed confocal endomicroscopy in combination with a 3-biomarker panel can inform management decisions in Barrett’s esophagus,"EL Bird-Lieverman, X Liu, T Nuckcheddy-Grant, H Bertrani, M O'Donovan, ...",NPG,,0,2015
Morphological and immunohistochemical profile of hereditary diffuse gastric cancer,"I Gullo, RS van der Post, C Oliveira, LH Tang, H Grabsch, M O'Donovan, ...","VIRCHOWS ARCHIV 467, S6-S6",,0,2015
A biomarker study of lapatinib in the neoadjuvant treatment of HER2 over expressing esophago-gastric adenocarcinoma (EGA),"NK De Silva, L Schulz, A Paterson, T Nuckcheddy-Grant, W Qain, ...","Cancer Research 75 (15 Supplement), 3596-3596",,0,2015
"Accuracy, safety, and tolerability of tissue collection by Cytosponge vs endoscopy for evaluation of eosinophilic esophagitis (vol 13, pg 77, 2015)","DA Katzka, DM Geno, A Ravi, TC Smyrk, P Lao-Sirieix, A Miremadi, ...","CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 13 (8), 1552-1552",,0,2015
Methods to predict progression of berret's esophagus to high grade dysplasia esophageal adenocarcinoma,"R Fitzgerald, E Bird-Lieberman","US Patent App. 14/401,725",,0,2015
AUTHENTICATION AND CHARACTERISATION OF A NEW OESOPHAGEAL ADENOCARCINOMA CELL LINE: MFD-1,"E Garcia, A Hayden, A Cowie, M Mellone, M Derouet, P Duriez, F Noble, ...","GUT 64, A125-A126",,0,2015
PTU-128 Novel insights into metastatic spread of oesophageal adenocarcinoma from whole genome sequencing data,"A Noorani, D Wedge, P Lao-Sirieix, J Weaver, N Grehan, I Debiram, ...","Gut 64 (Suppl 1), A119-A119",,0,2015
OC-040 First in-vivo study on the use of lectin-based molecular imaging in barrett’s oesophagus,"M Di Pietro, E Bird-Lieberman, T Nuckcheddy-Grant, I Debiram, ...","Gut 64 (Suppl 1), A21-A21",,0,2015
"PTH-184 Superior patient preference and high diagnostic accuracy for the detection of barrett’s oesophagus using a novel, portable, probe-based transnasal endoscope","SS Sami, M di Pietro, J Ortiz-Fernández-Sordo, J White, IN Guha, ...","Gut 64 (Suppl 1), A489-A490",,0,2015
PWE-171 Mobile element insertions are frequent and potentially mutagenic events in oesophageal carcinogenesis,"AL Paterson, JMJ Weaver, M Eldridge, S Tavare, RC Fitzgerald, ...","Gut 64, A287",,0,2015
PWE-177 The functional relevance of toll-like receptor 4 mutations in oesophageal adenocarcinoma,"DRF Elliott, B Verstak, X Li, MF Symmons, NJ Gay, RC Fitzgerald","Gut 64 (Suppl 1), A290-A290",,0,2015
PTH-167 Clinico-pathological characteristics of patients under barrett’s surveillance at a tertiary referral centre,"M Farrell, J Bornschein, S Zeki, M DiPietro, RC Fitzgerald","Gut 64 (Suppl 1), A482-A482",,0,2015
"Tu1529 Superior Patient Preference and High Diagnostic Accuracy for the Detection of Barrett's Esophagus Using a Novel, Portable, Probe-Based TransNasal Endoscope","SS Sami, M Di Pietro, J Ortiz-Fernández-Sordo, JR White, IN Guha, ...","Gastrointestinal Endoscopy 81 (5), AB497-AB498",,0,2015
Methods to assess the likelihood of dysplasia or esophageal adenocarcinoma,"R Fitzgerald, M Alvi, X Liu","US Patent App. 14/402,061",,0,2015
Outcomes of Eyes with Lesions Composed of> 50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT),"DF Williams, S Beardsley, S Bennett, H Cantrill, C Chan-Tram, ...","Ophthalmology 2 (122), 391-398. e5",,0,2015
Gastroenterology Part 2 of 4,"R Fitzgerald, M Parkes",,,0,2015
Whole Genome Sequencing of oesophageal adenocarcinoma: a progress update of the OCCAMS project,"A Noorani, J Weaver, C Ross-Innes, N Shannon, A Lynch, M Eldridge, ...",British Journal of Surgery 101,,0,2014
Inferring the clonal evolution of oesophageal adenocarcinoma through whole genome sequencing,"A Noorani, P Lao-Sirieix, D Wedge, J Weaver, N Grehan, ...","British Journal of Surgery 101, 44-45",,0,2014
Methods for detecting of benign conditions,"RC Fitzgerald, M O'donovan","US Patent App. 14/284,954",,0,2014
DEVELOPING MODEL SYSTEMS TO UNDERSTAND THE FUNCTIONAL AND CLINICAL SIGNIFICANCE OF SOMATIC GENETIC VARIATIONS IN OESOPHAGEAL CANCER,"T Underwood, E Garcia, A Howbrook, A Cowie, M Derouet, R Fitzgerald",Diseases of the Esophagus 27,,0,2014
384: The role of ODZ4 in epithelial cancers,"T Mirza, KD Howarth, E Turro, RC Fitzgerald, PAW Edwards","European Journal of Cancer 50, S91-S92",,0,2014
57: Early detection biomarkers for oesophageal cancer,"R Fitzgerald, RC Fitzgerald","European Journal of Cancer 50, S14",,0,2014
425: RUNX1 structural variants in oesophageal adenocarcinoma,"RCJ Hsu, RC Fitzgerald, PAW Edwards","European Journal of Cancer 50, S102",,0,2014
PTU-153 The Timing Of Oncogenic Events In The Evolution Of The Oesophageal Adenocarcinoma Genome And Implications For Clinical Diagnostics,"J Weaver, C Ross-Innes, N Shannon, A Lynch, M Murtaza, T Forshew, ...","Gut 63 (Suppl 1), A105-A106",,0,2014
The Toll-Like Receptor Pathway Is Recurrently Mutated in Esophageal Adenocarcinoma,"DRF Elliott, CS Ross-Innes, MD Eldridge, R Fitzgerald","GASTROENTEROLOGY 146 (5), S310-S310",,0,2014
Autofluorescence-Targeted Optical Biopsy Accurately Diagnoses Dysplasia in Barrett's Esophagus and Can Detect the Field of Molecular Change,"M di Pietro, EL Bird-Lieberman, X Liu, M ODonovan, R Fitzgerald","GASTROENTEROLOGY 146 (5), S312-S312",,0,2014
935 The Timing of Oncogenic Events in the Evolution of the Oesophageal Adenocarcinoma Genome and Implications for Clinical Diagnostics,"JM Weaver, C Ross-Innes, NB Shannon, A Lynch, T Forshew, M Barbera, ...","Gastroenterology 146 (5), S-161",,0,2014
Sa1843 The Toll-Like Receptor Pathway Is Recurrently Mutated in Esophageal Adenocarcinoma,"DRF Elliott, CS Ross-Innes, MD Eldridge, R Fitzgerald","Gastroenterology 146 (5), S-310",,0,2014
Sa1852 Autofluorescence-Targeted Optical Biopsy Accurately Diagnoses Dysplasia in Barrett's Esophagus and Can Detect the Field of Molecular Change,"M di Pietro, EL Bird-Lieberman, X Liu, M ODonovan, R Fitzgerald","Gastroenterology 146 (5), S-312",,0,2014
Method for determining if a subject has an increased likelihood of high grade dysplasia or esophageal adenocarcinoma,"M Di Pietro, R Fitzgerald, LIU Xinxue",,,0,2013
Polokinase-1 is a Therapeutic Target in Oesophageal Adenocarcinoma: P169,"R O'Neill, CA Ong, R Nenutil, B Vojtesek, R Fitzgerald, T Hupp",British Journal of Surgery 100,,0,2013
C-MYC AS A BIOMARKER IN BARRETT'S OESOPHAGUS,"S Varghese, CS Ross-Innes, P Lao-Sirieix, M O'Donovan, RC Fitzgerald","GUT 62, A119-A119",,0,2013
DEFINING CANCER RISK IN BARRETT'S OESOPHAGUS USING A 90-GENE SIGNATURE,"S Varghese, R Newton, CS Ross-Innes, KK Krishnadath, P Lao-Sirieix, ...","GUT 62, A12-A12",,0,2013
THE COMBINATION OF AUTOFLUORESCENCE IMAGING AND PROBE-BASED CONFOCAL LASER ENDOMICROSCOPY HAS AN EXCELLENT DIAGNOSTIC ACCURACY FOR DYSPLASIA IN BARRETT'S ESOPHAGUS,"M Di Pietro, E Bird-Lieberman, X Liu, M O'Donovan, RC Fitzgerald","GUT 62, A111-A112",,0,2013
OC-066 The Cancer Research UK (Cruk) Funded ICGC Oesophageal Adenocarcinoma Project: MRC Research Centre and Cruk Cambridge Research Institute,"JMJ Weaver, N Shannon, C Ross-Innes, A Lynch, T Forshew, M Barbera, ...","Gut 62 (Suppl 1), A29-A29",,0,2013
PTU-173 Gord Symptoms and Demographic Factors as a Pre-Screening tool for Barrett’S Oesophagus,"X Liu, A Wong, SR Kadri, M O’Donovan, P Lao-Sirieix, R Burnham, ...","Gut 62 (Suppl 1), A119-A119",,0,2013
PTU-172 C-Myc as a Biomarker in Barrett’S Oesophagus,"S Varghese, CS Ross-Innes, P Lao-Sirieix, M O’Donovan, RC Fitzgerald","Gut 62 (Suppl 1), A119-A119",,0,2013
Mo1899 In Vitro Toxicity Studies of Novel Lectin Probes Which Have Potential to Allow Endoscopic Detection of Dysplasia in Barrett's Esophagus During Surveillance,"EL Bird-Lieberman, P Lao-Sirieix, R Fitzgerald","Gastroenterology 144 (5), S-688",,0,2013
Sa2074 The mutational architecture of oesophageal adenocarcinoma,"JM Weaver, NB Shannon, A Lynch, C Ross-Innes, M O'Donovan, ...","Gastroenterology 144 (5), S-375",,0,2013
Mo1897 GORD Symptoms and Demographic Factors As a Pre-Screening Tool for Barrett's Oesophagus,"X Liu, A Wong, SR Kadri, M O'Donovan, P Lao-Sirieix, WR Burnham, ...","Gastroenterology 144 (5), S-687-S-688",,0,2013
Mo1856 Mutation of TP53 Creates an Opportunity for Synthetic Lethality in Esophageal Adenocarcinoma,"JR O'Neill, CAJ Ong, J Nicholson, R Nenutil, B Vojtesek, R Fitzgerald, ...","Gastroenterology 144 (5), S-676",,0,2013
Implications of false-negative F-18-FDG PET in staging oesophageal cancer,"B Al Suqri, L Wing, M Halim, K Balan, J Buscombe, N Carroll, R Hardwick, ...","EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 39, S515-S515",,0,2012
DYSREGULATION OF INFLAMMATORY PATHWAYS IN BARRETT'S OESOPHAGUS AND OESOPHAGEAL ADENOCARCINOMA: P11. 27,"N Shannon, C Ong, R Fitzgerald",Diseases of the Esophagus 25,,0,2012
A 3 MOLECULAR TARGET IMMUNOHISTOCHEMISTRY PANEL CAN AID PROGNOSTICATION OF PATIENTS WITH OESOPHAGO-GASTRIC CANCER: O03. 03,"C Ong, J Shapiro, K Nason, J Davison, X Liu, C Ross-Innes, N Shannon, ...",Diseases of the Esophagus 25,,0,2012
Receptor Tyrosine Kinase Over-Expression is a Frequent and Early Event in Oesophageal Carcinogenesis,"A Paterson, M O'Donovan, E Provenzano, L Murray, H Coleman, ...",The Journal of Pathology 228,,0,2012
"DIETARY DOCOSAHEXAENOIC ACID IS INVERSELY ASSOCIATED WITH THE RISK OF DEVELOPING OESOPHAGEAL ADENOCARCINOMA: A UK PROSPECTIVE STUDY IN THE EPIC-NORFOLK COHORT, USING …","L Alexandre, M Yates, R Luben, E Cheong, L Igali, R Fitzgerald, KT Khaw, ...","GUT 61, A300-A300",,0,2012
PTU-192 Time,"K Shariff, M Di Pietro, D Boerwinkle, X Liu, P Sirieix, E Walker, L Mills, ...",Gut 61 (Suppl_2),,0,2012
OC-017 TRIM44,"CA Ong, N Shannon, P Lao-Sirieix, C Ross-Innes, M O'Donovan, ...",Gut 61 (Suppl_2),,0,2012
PWE-020 Using microarray data to elucidate the molecular phenotype of a novel oncogene and identify a therapeutic strategy,"CAJ Ong, NB Shannon, OM Rueda, R Hardwick, C Caldas, RC Fitzgerald","Gut 61 (Suppl 2), A305-A305",,0,2012
PTU-218 Pilot randomised cross-over study comparing the efficacy of transnasal Endosheath® to standard endoscopy to detect Barrett's oesophagus,"KM Shariff, S Verghese, M O'Donovan, Z Abdullahi, J Blazeby, ...","Gut 61 (Suppl 2), A274-A274",,0,2012
"PWE-010 Dietary campesterol is inversely associated with the risk of developing oesophageal adenocarcinoma: a UK prospective study in the EPIC-Norfolk cohort, using information …","L Alexandre, M Yates, R Luben, E Cheong, L Igali, R Fitzgerald, KT Khaw, ...","Gut 61 (Suppl 2), A300-A300",,0,2012
PTU-192 Time: prospective study combining endoscopic trimodal imaging and molecular endpoints to risk stratify Barrett's oesophagus,"KM Shariff, M Di Pietro, D Boerwinkle, X Liu, PL Sirieix, E Walker, L Mills, ...","Gut 61 (Suppl 2), A263-A264",,0,2012
Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus.,"P Lao-Sirieix, S Boyle, A Cassidy, D Castillo, A Saadi, R Eskeland, ...",Proceedings of the National Academy of Sciences of the United States of …,,0,2012
TRIM44: From Prognosis to Therapy in Esophageal Adenocarcinoma and Breast Cancer,"CAJ Ong, N Shannon, P Lao-Sirieix, C Ross-Innes, M O'Donovan, ...","GASTROENTEROLOGY 142 (5), S60-S60",,0,2012
"Dietary Docosahexaenoic Acid is Inversely Associated With the Risk of Developing Esophageal Adenocarcinoma: A UK Prospective Study in the EPIC-Norfolk Cohort, Using Information …","L Alexandre, M Yates, R Luben, E Cheong, L Igali, R Fitzgerald, KT Khaw, ...","GASTROENTEROLOGY 142 (5), S640-S640",,0,2012
Su1173 DNA Methylation is a Biomarker for Dysplasia and Early-Stage Neoplasia in Barrett's Esophagus: From Discovery to a Phase 4 Prospective Validation Study,"MA Alvi, X Liu, M O'Donovan, N Shannon, KM Shariff, M di Pietro, ...","Gastroenterology 142 (5), S-443",,0,2012
Sa1795 Using Expression Array Data to Elucidate the Molecular Phenotype of a Novel Oncogene and Identify a Therapeutic Strategy,"CAJ Ong, N Shannon, OM Rueda, RH Hardwick, C Caldas, R Fitzgerald","Gastroenterology 142 (5), S-328",,0,2012
Do Transcription Factors Hold the Key to Understanding the Development of Barrett’s Esophagus?,RC Fitzgerald,"Digestive diseases and sciences 57 (4), 830-831",,0,2012
IMAGEN Y TECNOLOGÍA AVANZADA,"S VARGHESE, P LAO–SIRIEIX, RC FITZGERALD","Artículos destacados 142, 14",,0,2012
254 TRIM44: From Prognosis to Therapy in Esophageal Adenocarcinoma and Breast Cancer,"CA Johnny Ong, N Shannon, P Lao-Sirieix, C Ross-Innes, M ODonovan, ...","Gastroenterology-Orlando 142 (1), S",,0,2012
EPITHELIAL MESENCHYMAL TRANSITION OCCURS EARLY IN SQUAMOUS CELL LUNG CANCER DEVELOPMENT,"NM Cummings, DM Rassl, HC Boobier, J Gosney, AG Nicholson, ...","JOURNAL OF THORACIC ONCOLOGY 6 (6), S1083-S1083",,0,2011
Molecular Targets in Metastatic Lymph Nodes in Oesophageal Cancer Predict Patient Survival,"A Noorani, CAJ Ong, P Lao-Sirieix, B Mahler-Araujo, CJ Peters, ...","Gastroenterology 140 (5), S-223",,0,2011
Location of Nodal Involvement Influences the Outcome in Patients With Oesophageal Adenocarcinoma,"CAJ Ong, S Worster, A Noorani, RH Hardwick, CJ Peters, R Fitzgerald","Gastroenterology 140 (5), S-667-S-668",,0,2011
Novel prognostic targets identified using integrated analysis of copy number and expression data in esophageal adenocarcinoma,"XY Goh, MA Alvi, JRE Rees, SF Chin, JMJ Weaver, C Caldas, ...","Cancer Research 71 (8 Supplement), 2256-2256",,0,2011
Molecular imaging via novel application of fluorescent lectins permits rapid endoscopic identification of dysplasia in barrett's oesophagus,"EL Bird-Lieberman, AA Neves, P Lao-Sirieix, M O'Donovan, LB Lovat, ...","Gut 60 (1), A170",,0,2011
HOXB cluster genes are novel potential regulators of Barrett's oesophagus development,"M Di Pietro, RC Fitzgerald","Gut 60 (Suppl 1), A20-A21",,0,2011
DNA methylation as a biomarker of progression in barrett's carcinogenesis,"MA Alvi, NB Shannon, M O'Donovan, R Newton, L Wernisch, ...","Gut 60 (Suppl 1), A168-A169",,0,2011
A systematic approach to therapeutic target selection in gastro-esophageal adenocarcinoma,"AL Paterson, NB Shannon, P Lao-Sirieix, CJ Peters, M O'Donovan, ...","Gut 60 (Suppl 1), A20-A20",,0,2011
Novel prognostic targets identified using integrated analysis of copy number and expression data in oesophageal adenocarcinoma,"XY Goh, MA Alvi, J Rees, SF Chin, J Weaver, C Caldas, R Fitzgerald","Gut 60 (Suppl 1), A174-A174",,0,2011
"Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research (vol 47, pg 436, 2010)","RC Fitzgerald, R Hardwick, D Huntsman, NC Van Grieken","JOURNAL OF MEDICAL GENETICS 48 (3), 216-216",,0,2011
Barrett’s Oesophagus,R Fitzgerald,"Pre-Invasive Disease: Pathogenesis and Clinical Management, 315-340",,0,2011
www. medicinecpd. co. uk www. medicinejournal. co. uk,"R Fitzgerald, M Parkes",,,0,2011
NON-ENDOSCOPIC SCREENING FOR BARRETT'S OESOPHAGUS IN PRIMARY CARE: THE BEST STUDY,"R Fitzgerald, J Emery, K Sudarshan, P Lao-Sirieix, A Boussioutas, ...",Asia-pacific Journal of Clinical Oncology 6,,0,2010
A model to predict survival in oesophageal and junctional adenocarcinoma incorporating both clinical and molecular features: C02,"C Peters, CAJ Ong, J Rees, J Hardwick, S Vowler, C Zhang, V Save, ...",British Journal of Surgery 97,,0,2010
A model to predict survival in oesophageal and junctional adenocarcinoma incorporating both clinical and molecular features: 1D 92955,"J Peters, J Rees, R Hardwick, J Hardwick, S Vowler, C Ong, C Zhang, ...",Diseases of the Esophagus 23,,0,2010
Activation of Wnt and MAPK pathways in oesophageal adenocarcinoma and during progression of Barrett's oesophagus: 3B 131163,"N Shannon, R Fitzgerald",Diseases of the Esophagus 23,,0,2010
S1631 Hoxb Cluster Genes are Activated in Barrett's Carcinogenesis via Epigenetic Regulation,"M di Pietro, RC Fitzgerald","Gastroenterology 138 (5), S-242",,0,2010
Determination of MAPK and Wnt pathway activity in esophageal cancer,"NB Shannon, CJ Peters, JR Rees, JS Hardwick, C Zhang, RH Hardwick, ...","Cancer Research 70 (8 Supplement), 789-789",,0,2010
Chromosomal aberrations reveal novel genes with prognostic significance in esophageal adenocarcinoma,"XYC Goh, JRE Rees, SF Chin, S Newman, M O'Donovan, B YIstra, ...","Cancer Research 70 (8 Supplement), 1189-1189",,0,2010
1080l: Potential Application of Lectins As Molecular Imaging Tools to Detect Dysplasia in Barrett's Oesophagus Endoscopically,"EL Bird-Lieberman, AA Neves, M O'Donovan, P Lao-Sirieix, KM Brindle, ...","Gastrointestinal Endoscopy 71 (5), AB145",,0,2010
OC-060 A clinically applicable three gene signature is independently highly prognostic in oesophageal and junctional adenocarcinoma,"CJ Peters, JRE Rees, JS Hardwick, SL Vowler, CJ Ong, C Zhang, V Save, ...","Gut 59 (Suppl 1), A24-A25",,0,2010
PTU-019 Nasal or standard endoscopy (nose) for diagnosis of Barrett's oesophagus–efficacy and patient tolerance,"KM Shariff, EL Bird-Lieberman, M O'Donovan, Z Abdullahi, SL Vowler, ...","Gut 59 (Suppl 1), A56-A56",,0,2010
A multisystem selenoprotein disorder with a thyroid signature,"N Schoenmakers, E Schoenmakers, M Agostini, C Mitchell, L Papp, ...",Society for Endocrinology BES 2010 21,,0,2010
Muziekinstrumenten,"PF Peters, KT Bijsterveld","Kunst en Wetenschap 19 (3), 9-10",,0,2010
Cell Cycle Deregulation in Pre-neoplasia: Case Study of Barrett’s Oesophagus,"P Lao-Sirieix, RC Fitzgerald","Cell Cycle Deregulation in Cancer, 157-166",,0,2010
606 Integrated analysis of genome-wide copy number and expression changes reveals novel genes in oesophageal adenocarcinoma,"XY Goh, JRE Rees, AL Paterson, SF Chin, M O'Donovan, D Alderson, ...","Ejc Supplements 7 (8), 190",,0,2010
Generation and Validation of a Prognostic Gene Signature for Esophageal Adenocarcinoma,"CJ Peters, JR Rees, JS Hardwick, C Zhang, RH Hardwick, RC Fitzgerald","GASTROENTEROLOGY 136 (5), A91-A91",,0,2009
Lymph Node Location Improves the Prognostic Power of Esophageal Adenocarcinoma Staging,"CJ Peters, RH Hardwick, SL Vowler, RC Fitzgerald","GASTROENTEROLOGY 136 (5), A602-A603",,0,2009
T1931 Molecular Classification of Gastro-Esophageal Adenocarcinoma,"N Shannon, CJ Peters, JR Rees, JS Hardwick, C Zhang, RH Hardwick, ...","Gastroenterology 136 (5), A-603",,0,2009
M1956 Genetic Inhibition of Telomerase in Different Esophageal Cell Types Leads to the Induction of ALT,"A Queisser, M Thaler, A von Werder, N Hirt, H Kunert, F Mancke, ...","Gastroenterology 136 (5), A-455",,0,2009
T1912 Lectin Targeting of Glycan Alterations to Detect Dysplasia in Barrett's Esophagus,"EL Bird-Lieberman, P Lao-Sirieix, AA Neves, M O'Donovan, KM Brindle, ...","Gastroenterology 136 (5), A-599",,0,2009
Abstract# 858: Personalizing chemotherapy to improve esophago-gastric cancer outcomes,"A Paterson, T Gilmer, R Wooster, R Fitzgerald","Cancer Research 69 (9 Supplement), 858-858",,0,2009
575 Generation and Validation of a Prognostic Gene Signature for Esophageal Adenocarcinoma,"CJ Peters, JR Rees, JS Hardwick, C Zhang, RH Hardwick, RC Fitzgerald","Gastroenterology 136 (5), A-91",,0,2009
T1929 Lymph Node Location Improves the Prognostic Power of Esophageal Adenocarcinoma Staging,"CJ Peters, RH Hardwick, SL Vowler, RC Fitzgerald","Gastroenterology 136 (5), A-602-A-603",,0,2009
PERSONALISING CHEMOTHERAPY TO IMPROVE OESOPHAGOGASTRIC CANCER OUTCOMES,"AL Paterson, TM Gilmer, RF Wooster, RC Fitzgerald","GUT 58, A31-A32",,0,2009
CDX2-DEPENDENT HOX GENE REGULATION IN BARRETT'S OESOPHAGUS,"M di Pietro, RC Fitzgerald","GUT 58, A142-A143",,0,2009
"Reminder of important clinical lesson: The definition and management of Barrett’s oesophagus: a case report, review of the literature and a suggestion for the future","EL Bird-Lieberman, P Lao-Sirieix, I Saeed, D Khoo, R Burnham, ...",BMJ Case Reports 2009,,0,2009
ERBB2 EXPRESSION IN OESOPHAGEAL ADENOCARCINOMA AND BARRETT’S OESOPHAGUS: DEMONSTRATING THE POTENTIAL FOR A PRE-EMPTIVE STRIKE,"AL Paterson, E Provenzano, M O Donovan, SE Davies, MR Novelli, ...","Gut 58 (Suppl 1), PT283-",,0,2009
Epigenetic changes wipe out protective mechanisms in Barrett’s oesophagus,RC Fitzgerald,"Gut 58 (1), 1-2",,0,2009
The incidence of involved lymph nodes in oesophageal adenocarcinoma-implications for preoperative staging,"C Peters, R Fitzgerald, S Vowler, J Rees, P Safranek, V Save, N Carroll, ...",British Journal of Surgery 95,,0,2008
Using a revised N-stage to predict individual patient outcome for oesophageal adenocarcinoma: ID 530 Reference ABS2143575551,"C Peters, R Fitzgerald, S Vowler, J Rees, P Safranek, V Save, N Carroll, ...","British Journal of Surgery 95, 10-11",,0,2008
Understanding molecular pathogenesis of Barrett's adenocarcinoma and application to the clinic,R Fitzgerald,The Journal of Pathology 216,,0,2008
An improved staging system for esophageal adenocarcinoma based on the number of involved lymph nodes,"CJ Peters, RH Hardwick, JR Rees, SL Vowler, PM Safranek, V Save, ...","GASTROENTEROLOGY 134 (4), A302-A302",,0,2008
M1936 Identification and Validation of Biomarkers for Use in Barrett's Oesophagus Screening,"P Lao-Sirieix, A Boussioutas, L Harihar, R Fitzgerald","Gastroenterology 134 (4), A-434",,0,2008
W1949 C-MET Amplification in Oesophageal Adenocarcinoma Cell Lines Influences EGFR and Erbb2 Phosphorylation Status and May Provide Resistance to ERBB Targeted Therapies,"AL Paterson, H Shi, L Liu, TM Gilmer, RF Wooster, R Fitzgerald","Gastroenterology 134 (4), A-740",,0,2008
Therapeutic Advances in Gastroenterology Acknowledgements,"J Abrams, A Agrawal, K Andersson, A Bajor, O Barbier, KD Bardhan, ...","Gastroenterology 1 (3), 201",,0,2008
A potential role for periostin in barrett's carcinogenesis,"A Saadi, M Das, N Clemons, C Zhang, G Tokiwa, K Serikawa, M Ferguson, ...","GUT 57, A128-A128",,0,2008
An improved staging system for oesophageal adenocarcinoma based on the number of involved lymph nodes,"CJ Peters, RH Hardwick, JRE Rees, SL Vowler, PM Safranek, V Save, ...","GUT 57, A13-A14",,0,2008
Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus. Commentary,"RC FITZGERALD, SJ LEEDHAM, SL PRESTON, SAC MCDONALD, ...",Gut 57 (8),,0,2008
EGFR and erbb2 phosphorylation status: Implications for erbb targeted therapies,"AL Paterson, HZ Shi, L Liu, TM Gilmer, RF Wooster, RC Fitzgerald","GUT 57, A127-A128",,0,2008
The origin and prevention of Barrett's esophagus,R Fitzgerald,"Cancer Epidemiology and Prevention Biomarkers 16 (12 Supplement), CN17-03 …",,0,2007
A potential role for Periostin in Barrett’s carcinogenesis,"A Saadi, M Das, N Clemons, C Zhang, M Ferguson, G Tokiwa, K Serikawa, ...","Cancer Epidemiology and Prevention Biomarkers 16 (12 Supplement), B28-B28",,0,2007
The resection margin is highly prognostically significant in oesophageal cancer,"C Peters, J Rees, S Vowler, P Safranek, V Save, S Dwerryhouse, ...",British Journal of Surgery 94,,0,2007
The number of involved lymph nodes is prognostic in oesophageal adenocarcinoma-is it time to change how we stage the disease?,"C Peters, J Rees, S Vowler, P Safranek, V Save, N Carroll, ...",British Journal of Surgery 94,,0,2007
In vivo evidence for epithelial to mesenchymal transition (EMT) in oesophageal adenocarcinoma with associated alteration in TGF-β signalling at a chromosomal level,"J Rees, SF Chin, J Marioni, B Ylstra, V Save, C Caldas, R Hardwick, ...",British Journal of Surgery 94 (8),,0,2007
Inactivation of the second allele in patients with hereditary diffuse gastric cancer harbouring germline E-cadherin mutations,"M Barber, S Hyland, N Grehan, C Caldas, R Fitzgerald","Cancer Research 67 (9 Supplement), 1145-1145",,0,2007
Oxidative and nitrosative stress-induced DNA damage in esophageal adenocarcinoma,"N Clemons, R Fitzgerald","Cancer Research 67 (9 Supplement), 900-900",,0,2007
Array CGH detected genomic aberrations in oesophagogastric cancer identify potential diagnostic and therapeutic targets,"J Rees, SF Chin, J Marioni, C Caldas, V Save, B Ylstra, D Alderson, ...","Cancer Research 67 (9 Supplement), 2937-2937",,0,2007
226 NOVEL GENOMIC ABERRATIONS IN OESOPHAGOGASTRIC CANCER,"JR Rees, S Chin, JC Marioni, C Caldas, V Save, B Ylstra, D Alderdson, ...",Gut 56,,0,2007
I left work three years ago when I had twins. Now they are going to nursery. Could you advise me how to get back in the NHS. I finished my house job in 2003.,R Fitzgerald,"BMJ 334 (7589), s56-s56",,0,2007
I am currently a fourth year medical student. I was hoping for some advice on the academic foundation placements. Do you know how many are available?,R Fitzgerald,"BMJ 334 (7583), s2-s2",,0,2007
EMT in esophageal adenocarcinoma,"JRE Rees, BA Onwuegbusi, VE Save, D Alderson, RC Fitzgerald","CANCER RESEARCH 67 (1), 427-427",,0,2007
Alarm symptoms,"E Bird-Lieberman, R Fitzgerald","Medicine 4 (35), 199-203",,0,2007
Retinoic acid-induced glandular differentiation of the oesophagus. Commentary,"CC MALEY, CL CHANG, P LAO-SIRIEIX, V SAVE, ...",Gut 56 (7),,0,2007
"What are the realistic implications of finding a job for somebody who has been convicted of a minor charge? If it is too difficult to find a medical job, should I give up …",R Fitzgerald,"BMJ 333 (7570), s122-s122",,0,2006
Nitrosative stress in the development and progression of oesophageal adenocarcinoma,"NJ Clemons, R Abeyratne, RC Fitzgerald","Journal of Clinical Gastroenterology 40, S168",,0,2006
PRE-OPERATIVE EUS BASED STAGING CAN ACCURATELY PREDICT OUTCOME IN OESOPHAGOGASTRIC CANCER: FC 2.09,"J Rees, R Hardwick, S Vowler, D Alderson, R Fitzgerald",The Official Journal of The International Hepato Pancreato Biliary Association 8,,0,2006
Pathogenesis of Barrett's Esophagus,"NJ Clemons, RC Fitzgerald, MJG Farthing","Barrett's Esophagus and Esophageal Adenocarcinoma, 27-37",,0,2006
I am currently approaching my third year of specialist training in endocrinology/diabetes. I now feel that I have made the wrong choice and would like to change specialty to …,R Fitzgerald,"BMJ 332 (7551), s198-s198",,0,2006
Evidence from Barrett's carcinogenesis that CYP26A1 is implicated in cancer,"CL Chang, P Lao-Sirieix, RC Fitzgerald","GASTROENTEROLOGY 130 (4), A411-A411",,0,2006
Dual roles for nitric oxide in the development and progression of Barrett's adenocarcinoma,"N Clemons, R Abeyratne, RC Fitzgerald","GASTROENTEROLOGY 130 (4), A566-A566",,0,2006
In vivo and in vitro evidence for epithelial to mesenchymal transition (EMT) in oesophageal adenocarcinoma,"JR Rees, BA Onwuegbusi, VE Save, D Alderson, RC Fitzgerald","GASTROENTEROLOGY 130 (4), A676-A676",,0,2006
075 REACTIVE OXYGEN SPECIES INDUCED DNA DAMAGE IN OESOPHAGEAL ADENOCARCINOMA,"NJ Clemons, RC Fitzgerald",Gut 55,,0,2006
Somatic mutation as a possible'Second hit'in hereditary diffuse gastric cancer patients with E-cadherin germ-line mutations,"M Barber, S Hyland, N Grehan, C Bordin, C Caldas, R Fitzgerald","GASTROENTEROLOGY 130 (4), A638-A638",,0,2006
"408 THE BILE ACID, LITHOCHOLIC ACID, ACTIVATES RETINOID SIGNALING IN BARRETT’S OESOPHAGEAL CELL LINES","C Chang, RC Fitzgerald",Gut 55,,0,2006
I am approaching my third year of specialist training in endocrinology and diabetes. I feel I've made the wrong choice and want to change to gastroenterology. How feasible is …,R Fitzgerald,"BMJ 332 (7541), s92-s92",,0,2006
"Comparative genomic hybridization of esophageal adenocarinoma and squamous cell carcinoma cell lines. Diseases of the esophagus 2006 (vol 19, pg 10, 2006","M Su, SF Chin, XY Li, P Edwards, C Caldas, RC Fitzgerald","DISEASES OF THE ESOPHAGUS 19 (2), 135-135",,0,2006
Effect of acid suppression on the proliferation status of Barrett’s oesophagus,"P Lao-Sirieix, A Roy, R Fitzgerald","Cancer Research 65 (9 Supplement), 1147-1147",,0,2005
Novel mechanism of p14ARF gene silencing in esophageal cancer,"Y Huang, R Gjerset, R Fitzgerald","Cancer Research 65 (9 Supplement), 430-430",,0,2005
Transforming Growth Factor Beta (TGFβ) induced epithelial to mesenchymal transformation in esophageal adenocarcinoma; implications for invasion and metastasis,"JR Rees, BA Onwuegbusi, RC Fitzgerald","Cancer Research 65 (9 Supplement), 1326-1326",,0,2005
Altered retinoic acid signalling and its relationship to Cdx-2 in Barrett’s oesophagus and associated carcinogenesis,"CL Chang, G De La Cueva-Mèndez, P Lao-Sirieix, R Laskey, R Fitzgerald","Cancer Research 65 (9 Supplement), 922-923",,0,2005
089 EPITHELIAL TO MESENCHYMAL TRANSFORMATION IN VITRO INDUCED BY TRANSFORMING GROWTH FACTOR BETA IN OESOPHAGEAL ADENOCARCINOMA,"JRE Rees, BA Onwuegbusi, RC Fitzgerald",Gut 54,,0,2005
I am ambitious and family life is important to me. Are there any female oncologists who would recommend clinical oncology as an option where one can have both a career and a …,R Fitzgerald,"BMJ 330 (7483), s22-s22",,0,2005
Effect of inflammation on cyclooxygenase (COX)-2 expression in benign and,R Fitzgerald,,,0,2005
Defective TGF-[beta] signalling in the Barrett's metaplasia-dysplasi-adenocarcinoma sequence,"BA Onwuegbusi, RC Fitzgerald","Gut 53 (4), A60-A60",,0,2004
Cell cycle phase distribution in neoplastic progression of Barrett's oesophagus,"P Lao-Sirieix, R Brais, N Coleman, R Fitzgerald","Gut 53 (4), A26-A26",,0,2004
Defective TGF beta signalling throughout the Barrett's metaplasia-dysplasia-adenocarcinoma sequence,"BA Onwuegbusi, RC Fitzgerald","GASTROENTEROLOGY 126 (4), A235-A235",,0,2004
Helicobacter pylori infection and severity of oesophageal disease in a cohort of of patients with Barrrett's oesophagus,"JR Ramus, PAC Gatenby, CPJ Caygill, RC Fitzgerald, A Watson","Gut 63, A61-A61",,0,2004
Relationship of COX-2 expression to gastrin and cell differentiation status in Barrett's esophagus and associated carcinoma,"S Abdalla, P Lao-Sirieix, M Novelli, LB Lovat, RC Fitzgerald","Clinical Cancer Research 10, 4784-4792",,0,2004
Relationship of presenting symptoms to outcome in columnar-lined oesophagus (CLO).,"PAC Gatenby, JR Ramus, CPJ Caygill, RC Fitzgerald, A Watson","Gut 63, A101-A101",,0,2004
Time course of metaplastic and dysplastic changes in columnar-lined oesophagus (CLO) and relationship to symptom onset.,"PAC Gatenby, JR Ramus, CPJ Caygill, RC Fitzgerald, A Watson","Gut 63, A99-A99",,0,2004
Mini-chromosome maintenance proteins provide a novel method for detecting patients at risk of developing adenocarcinoma in Barrett's oesophagus,"PS Sirieix, M O'Donovan, J Brown, N Coleman, RC Fitzgerald","GUT 52, A46-A46",,0,2003
Oesophageal cancer,"H Barr, RC Fitzgerald, AH Ormsby, RE Petras, WH Henricks, TW Rice, ...","Gut 52 (1), 14-15",,0,2003
Association between lifestyle factors and histology in Barrett's Oesophagus,"PAC Gatenby, JR Ramus, CPJ Caygill, A Watson, RC Fitzgerald","Gut 52, A221-",,0,2003
"Molecular Oncology, Markers, Clinical Correlates-Surface Expression of Minichromosome Maintenance Proteins Provides a Novel Method for Detecting Patients at Risk for Developing …","PS Sirieix, M O'Donovan, J Brown, V Save, N Coleman, RC Fitzgerald","Clinical Cancer Research 9 (7), 2560-2566",,0,2003
Role for Cytokines in the Aetiopathogenesis of the Premalignant Condition Barrett's Oesophagus,"RC Fitzgerald, BA Onwuegbusi","Clinical Science 103 (s47), 38P-38P",,0,2002
Cytokines induce preferential squamous epithelial cell repair following photodynamic therapy for patients with Barrett's oesophagus: An in vitro model,"TKL Wong, LB Lovat, P Sirieix, RC Fitzgerald","GUT 50, A6-A6",,0,2002
Variations in cytokine expression in the malignant progression of Barrett's oesophagus and following photodynamic therapy,"P Sirieix, TKL Wong, LB Lovat, RC Fitzgerald","GUT 50, A37-A37",,0,2002
Treatment of Barrett's Oesophagus,"A Wong, J Goh, RC Fitzgerald",Cochrane Database of Systematic Reviews,,0,2002
"Author and Subject Index Vol. 20, No. 1, 2002","RC Fitzgerald, C Caldas, A Reinacher-Schick, W Schmiegel, ...","Digestive Diseases 20 (1), 106-106",,0,2002
Importance of metaplastic subtypes and squamo-columnar cross-talk in the aetiopathogenesis of inflammatory and malignant complications in Barrett's oesophagus (BE),"SA Abdalla, RC Fitzgerald, BA Onwuegbusi, MJG Farthing","Gut 48 (3), A16-A16",,0,2001
HUMAN AND MURINE DATA SUGGEST CRITICAL ROLE FOR TGF-[beta] IN THE AETIOPATHOGENESIS OF BARRETT'S OESOPHAGUS,"RC Fitzgerald, BA Onwuegbusi, GA Depaulo, RM Feakins, LA McKinney, ...","Gut 48 (3), A29-A29",,0,2001
An in vitro study of the effects of cytokines on oesophageal repair following mechanical and PDT injury,"T Wong, P Sirieix, B Onwuegbusi, LB Lovat, RC Fitzgerald","European Journal of Surgical Oncology 27, 624-",,0,2001
Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats. Commentary,"RC FITZGERALD, TY OH, JS LEE, BO AHN, H CHO, WB KIM, YB KIM, ...","Gut 49 (3), 364-371",,0,2001
Characterization of intracellular Ph control in Barrett's oesophagus: Evidence for an adaptive cellular response to gastro-oesophageal reflux,"RC Fitzgerald, MJG Farthing, G Triadafilopoulos","GUT 46, A58-A58",,0,2000
The role of transforming growth factor beta and its receptors in the development and progression of Barrett's oesophagus,"G De Paulo, RC Fitzgerald, BA Onwuegbusi, R Faekins, MJ Farthing","Gastroenterology 118 (4), A1066",,0,2000
Importance of adequate acid suppression in the management of Barrett's esophagus-Reply,"R Ouatu-Lascar, RC Fitzgerald, G Triadafilopoulos","GASTROENTEROLOGY 117 (6), 1510-1510",,0,1999
Alcohol intake and cancer of the upper digestive tract,"R Fitzgerald, C Caygill",Bmj 318 (7193),,0,1999
Alcohol intake and cancer of the upper digestive tract. Treating upper digestive tract cancers as a single entity may be misleading.,"R Fitzgerald, C Caygill","BMJ (Clinical research ed.) 318 (7193), 1291-1291",,0,1999
Rigorous surveillance protocol increases the detection for Barrett's oesophagus associated adrenocarcinomas,"RC Fitzgerald, IT Saeed, D Khoo, WR Burnham","GUT 44, A6-A6",,0,1999
Rigorous surveillance protocol increases the detection for Barrett's oesophagus associated adenocarcinomas,"RC Fitzgerald, IT Saeed, D Khoo, WR Burnham",Gut 44,,0,1999
Alcohol intake and cancer of the upper digestive tract,"CL Vecchia, KK Cheng, V Reed, R Fitzgerald, C Caygill, M Gronbaek, ...","BMJ-British Medical Journal-International Edition 318 (7193), 1289-1290",,0,1999
Consideration of histopathological subtypes and biopsy techniques in Barrett's oesophagus surveillance programmes,"R FITZGERALD, W BURNHAM, C MACDONALD, A WICKS, ...","Gut 42 (3), 448",,0,1998
Stress protein response in human oesophageal epithelium may be influenced by the ex vivo culture technique,RC Fitzgerald,"Gut 42 (2), 307-308",,0,1998
Altered NA-H exchange activity explains acid-pulse induced hyperproliferation in Barrett's esophagus ex-vivo.,"RC Fitzgerald, MB Omary, G Triadafilopoulos","GASTROENTEROLOGY 112 (4), A561-A561",,0,1997
Molecular Changes in Barrett's Oesophagus: The Dynamic Effect of Acid on the Metaplastic Cell Phenotype,RC Fitzgerald,University of Cambridge,,0,1997
Dynamic effects of acid on differentiation and proliferation of HT29 cells: An in vitro model for Barrett's esophagus,"RC Fitzgerald, MB Omary, G Tridafilopoulos","MOLECULAR BIOLOGY OF THE CELL 7, 1062-1062",,0,1996
Domiciliary Treatment of Tuberculosis,"R FitzGerlad, PT Garry, MJ O'Donnell, TA Jermy, TAG Hudson, J Binnie, ...","British medical journal 2 (4674), 369",,0,1950
A seven gene signature outperforms clinical features at predicting survival in oesophageal adenocarcinoma: A01,"C Peters, J Rees, J Hardwick, C Zhang, R Fitzgerald, R Hardwick",British Journal of Surgery 96,,0,0
Sir Nicholas A. Wright,"RM Peek Jr, DA Corley, R Fitzgerald, S Lu, J Maher, HR Berthoud, ...",,,0,0
Stefan Zeuzem,"RM Peek Jr, DA Corley, R Fitzgerald, S Lu, J Maher, HR Berthoud, ...",,,0,0
Protective benefits of columnar epithelium in Barrett's esophagus Reduced esophageal acid sensitivity,"RC Fitzgerald, R Lascar, BS Kaur, G Triadafilopoulos",,,0,0
MRC Cancer Unit,R Fitzgerald,,,0,0
IP-2 COMPARISON OF THROUGH THE SCOPE (TTS) BALLOON DILATORS WITH MECHANICAL DI-LATORS IN PATIENTS WITH BENIGN ESOPHA-GEAL STRICTURE,"T Yamada, K Sugimoto, M Di Pietro, R Fitzgerald",,,0,0
"Richard M. Peek, Jr.","DA Corley, R Fitzgerald, S Lu, J Maher, HR Berthoud, JF Colombel, ...",,,0,0
Evaluation of a Non-Endoscopic Immunocytological Device (Cytosponge) for Barrett’s Esophagus Screening in a Case-Control Study (BEST2),R Fitzgerald,,,0,0
John F. Kuemmerle,"RM Peek Jr, DA Corley, R Fitzgerald, S Lu, J Maher, HR Berthoud, ...",,,0,0
Rank Prize Funds Lecture,"JMW Slack, BJ Colleypriest, JM Quinlan, WY Yu, JM Farrant, D Tosh, ...",,,0,0
Chromosome translocations and other genome rearrangements in oesophageal adenocarcinoma,"P Edwards, R Fitzgerald",,,0,0
Cell populations at risk for dysplasia Increased cell proliferation,"RC Fitzgerald, R Lascar, BS Kaur, G Triadafilopoulos",,,0,0
"NICHOLAS J. SHAHEEN, MD, MPH","T ARAKAWA, DA CARLSON, ES DELLON, M DI PIETRO, R FASS, ...",,,0,0
xxxiv Small Bowel Capsule Impaction and Successful Endoscopic Retrieval,"RM Arifuddin, MM Baichi, PS Mantry, A Wong, RC Fitzgerald",,,0,0
Correction to Lancet Gastroenterol Hepatol 2017; 2: 32–42,"DR Fels Elliott, AW Walker, M O’Donovan, J Parkhill, RC Fitzgerald",,,0,0
